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CHAPTER 1 – INTRODUCTION
(This chapter contains previously published material. See Appendix A.)
Embryonic stem cells (ESCs) and their development
Stem cells are widely studied as they provide a suitable cell replacement source for
research and clinical therapy (Gao et al., 2018; Huang and Zhang, 2019; Mead et al., 2015). Stem
cells have two properties, which are self-renewal and pluripotency (He et al., 2009; Liu et al.,
2019). Stem cells are mainly divided into three types of cells by their origins: ESCs, tissue-specific
stem cells, and induced pluripotent stem cells (Li et al., 2016; Lin et al., 2017; Thomson et al.,
1998). In this dissertation, we mainly focus on the research of the ESCs.
Embryonic stem cells (ESCs) are collected from the inner cell mass of the blastocyst in the
early stages of embryonic development, followed by cell line established and cultured in vitro for
further study (Baldwin, 2009; Biswas and Hutchins, 2007; Thomson et al., 1998). ESCs
demonstrate a high capacity for self-renewal and pluripotency, as summarized in Figure 1. Firstly,
the ESCs can be kept in the undifferentiated stage in vitro by culture with a feeder cell layer,
specific serum, or leukemia inhibitory factor (LIF) treatment (Biswas and Hutchins, 2007;
Fleischmann et al., 2009; Ludwig and J, 2007; Martello and Smith, 2014; Wei et al., 2018). The
undifferentiated ESCs have the ability of differentiation and proliferation. The ESCs will support
a stable and abundant source of cells for further research and clinical application. Secondly, ESCs
have a strong ability of pluripotency. ESCs can differentiate into primitive ectoderm cells, which
can then differentiate into any of the three primary germ layer cell types (mesoderm, ectoderm,
and endoderm) during gastrulation in vivo (Baldwin, 2009; Thomson et al., 1998). These three
cell types have the incredible capacity to differentiate into approximately 220 different types of
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mature cells to carry out specific functions in vivo. Moreover, many papers reported that similar
to their in vivo development, ESCs can be manipulated in vitro to cause differentiation into
various cell types, such as nerve cells, bone cells, blood cells, and immune cells (Kuhn et al., 2014;
Liu et al., 2018b; Smith et al., 2015; Vanhee et al., 2015; Yang et al., 2008). In this dissertation,
we mainly focus on neural regeneration from ESCs.

Figure 1. Diagram representing embryonic stem cell (ESC) properties. ESCs possess two unique
properties, which are self-renewal and pluripotency. For self-renewal (red arrow), ESCs can be
kept in the undifferentiated stage and they can proliferate into new ESCs with the properties of
the previous cell (Biswas and Hutchins, 2007; Fleischmann et al., 2009; Ludwig and J, 2007;
Martello and Smith, 2014; Wei et al., 2018). For the pluripotent (green arrow), ESCs can
differentiate into variety of cell types, such as fat cells, neurons, muscle cells, immune cells, and
bone cells (Kuhn et al., 2014; Liu et al., 2018b; Smith et al., 2015; Vanhee et al., 2015; Yang et al.,
2008). The diagram was self-designed and all contents were based on studies and conclusions in
the following literature (Biswas and Hutchins, 2007; Fleischmann et al., 2009; Kuhn et al., 2014;
Liu et al., 2018b; Ludwig and J, 2007; Martello and Smith, 2014; Smith et al., 2015; Vanhee et al.,
2015; Wei et al., 2018; Yang et al., 2008).
Neural differentiation of ESC
Newly generated ESC-derived neurons have been widely used in stem cell and neuron
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replacement research (Craff et al., 2007; Han and Hu, 2020; Liu et al., 2018b). Based on the
requirements of the newly generated neurons, there are several methods used to generate
different types of neurons from the ESCs (Figure 2). The ESCs are cultured as an embryoid body

Figure 2. Diagram showing the neural differentiation of ESCs. Several methods were used to
guide ESCs differentiate into different type of neurons. For example, brain-derived neurotrophic
factor (BDNF), fibroblast growth factor 4 (FGF-4), and sonic hedgehog (Shh) treatment can guide
the dopamine neurons generation (Alizadeh et al., 2019; Malczynska et al., 2019), insulin-like
growth factor 1 (IGF-I) and glial cell line-derived neurotrophic factor (GDNF) treatment can guide
the motor neurons generation (Fang et al., 2019; Rabinovsky et al., 2003), fibroblast growth
factor 8b (FGF-8b) and (bone morphogenetic protein) BMP treatment can guide the
glutamatergic neurons generation (Liu et al., 2018b), and BDNF, GFND, IGF-1, neurotrophin-4
(NT-4), and Shh treatment can guide the GABAergic neurons generation. Previously, we reported
a novel neural differentiation method to generate glutamatergic bipolar neurons from ESCs via
retinoic acid (RA), epidermal growth factor (EGF), FGF-2, and nerve growth factor (NGF)
treatment (Liu et al., 2018b). The diagram was self-designed and all contents were based on
studies and conclusions in the following literature (Alizadeh et al., 2019; Fang et al., 2019; Liu et
al., 2018b; Malczynska et al., 2019; Rabinovsky et al., 2003).
at the early stage, followed by chemical treatments to induce the ESCs to differentiate into neural
progenitor cells (Ouyang et al., 2015; Shparberg et al., 2019). At the mid- and end-stages of the
neural differentiation, different growth factors or cytokines are used to treat the cells to generate
different neuron types. Specifically, ESCs can differentiate into the dopamine neurons via brain-

4
derived neurotrophic factor (BDNF), fibroblast growth factor 4 (FGF-4), and sonic hedgehog (Shh)
treatments (Alizadeh et al., 2019; Malczynska et al., 2019). The ESCs can differentiate into the
motor neurons via insulin-like growth factor 1 (IGF-I) and glial cell line-derived neurotrophic
factor (GDNF) treatments (Fang et al., 2019; Rabinovsky et al., 2003). The ESCs can differentiate
into glutamatergic neurons via fibroblast growth factor 8b (FGF-8b) and bone morphogenetic
protein (BMP) treatments (Liu et al., 2018b). The ESCs can differentiate into GABAergic neurons
via BDNF, GDNF, IGF-1, neurotrophin-4 (NT-4), and Shh treatments (Wang et al., 2008).
Liu and colleagues of Dr. Hu’s laboratory (2018) have previously reported a novel neural
differentiation method to generate bipolar glutamatergic neurons from ESCs in vitro (Figure 3A-

Figure 3. “Step by step” neural differentiation of the ESCs. (A) Diagram of the “step by step”
neural differentiation from the ESC cell line (4C2). (B) Bright field images showed the cell
morphology of the different differentiation time points, including non-neural ectoderm (NNE),
otic placode and otocyst (OPO), NB, and ESN. (C) The immunofluorescence images showed the
ESNs were double label by two neuron markers TUJ1 and NeuN. Diagram and figures representing
a particular generation process of ESN and based on study from Liu and colleagues (Liu et al.,
2018b). Scale bars in B and C are 50 μm.
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B) (Liu et al., 2018b). This new neural differentiation method mimics the physiological process of
neuron development. ESCs were treated with retinoic acid (RA) to form the neuroblasts (NBs) at
the early stage. At the mid- and end-stage (cell differentiation period from neural stem cell to
neuron was defined as mid- and end- stage) of the neural differentiation, the epidermal growth
factor (EGF), FGF-2, and nerve growth factor (NGF) were used to treat the NBs to differentiate
into ESC-derived neurons (ESNs). These ESNs showed bipolar morphology and expressed neuronspecific genes and proteins (Figure 3C) (Liu et al., 2018b).
The newly generated neurons need to have native neuronal function, including the ability
to transmit signals between cells, if they are to be used for neuron replacement therapy. In our
previous report, ESNs were showed to have the ability of making connections with endogenous
neurons and sensory cells in vitro for signal transfer (Figure 4) (Liu et al., 2018b). The regenerated

Figure 4. Diagram representing properties of ESNs connected with a hair cell and CN neuron.
(A) Diagram of a tri-culture of a green fluorescent protein prelabeled ESN (GFP-ESN), a native hair
cell and a CN neuron. (B) Diagram of a hair cell, ESN, and CN connection in vitro. Ctbp2 which is
the hair cell synapse marker expressed in the ESN connected hair cell. The CN neuron can receive
ESN’s electrophysiological signal via ESN-CN connection in vitro (Liu et al., 2018b). All contents
were based on study from Liu and colleagues (Liu et al., 2018b).
ESNs are a potential cell source for neuron replacement research and therapy (Craff et al., 2007;
Han and Hu, 2020; Liu et al., 2018b). However, the newly generated ESNs had some
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disadvantages: (1) The regeneration yield of ESNs was low, which mean less neurons were
available at the end of experiments; (2) The ESNs’ neurites were short and nondirective, which
limited for the formation of the connection; (3) The synapses between ESNs and native neurons
were immature, showing low expression of the synapse vehicle & protein markers, and low
electrophysiology activity compared with native neurons. These disadvantages may limit their
therapeutic effect. In this dissertation, we sought to overcome these limitations via novel
methodology.
Biomaterial-induced cell growth and differentiation
Two methods exist for stimulating neural differentiation: the biochemical signal
stimulation method and the physical signal stimulation method (Figure 5). The biochemical

Figure 5. Diagram of the factors that induce cellular responses in ESC. Bio-chemical signals
(Dong et al., 2017; Hu et al., 2019; Lau and Hudson, 2010; Li et al., 2016), which include growth
factor, cytokines, chemokines, and gene editing and physical signals, which included topography,
stiffness, and force, can contribute the ESC’s cellular response, such as self-renewal, neural
differentiation, neurite outgrowth & elongation, and synaptogenesis (Jain et al., 2020; Zhu et al.,
2019; Zimmermann and Schaffer, 2019). The diagram was self-designed and all contents were
based on studies and conclusions in the following literature (Dong et al., 2017; Hu et al., 2019;
Jain et al., 2020; Lau and Hudson, 2010; Li et al., 2016; Zhu et al., 2019; Zimmermann and
Schaffer, 2019).
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Signal stimulation method uses growth factors, cytokines, chemokines, small molecular
treatment, or gene editing methods to stimulate neural differentiation and neuron maturation
(Dong et al., 2017; Hu et al., 2019; Lau and Hudson, 2010; Li et al., 2016). The physical signal
stimulation method alters the microenvironment to stimulate cell proliferation, differentiation,
and maturation (Jain et al., 2020; Zhu et al., 2019; Zimmermann and Schaffer, 2019). In this
context, the microenvironment includes matrix topography, matrix stiffness, and mechanical
forces. The extracellular matrix has been reported to stimulate neural differentiation from the
neural stem cells via the integrin receptor (Long and Huttner, 2019; Pan et al., 2014). The micropattern matrix can guide neuron growth and migration (Cheng and Kisaalita, 2010; Yang et al.,
2005). The micro-fluid solution can stimulate neuron growth (Neto et al., 2016). In addition, the
micro-electric field can stimulate neurite elongation and synaptogenesis (Alexander et al., 2006;
McCaig et al., 2000). However, there are fewer reports that micro-patterns could stimulate neural
differentiation. Moreover, the range of functional sizes of the micro- (10- 1000 μm), submicro(1- 10 μm), and nano- (0.1- 1 μm) patterns to guide neurite outgrowth and neural differentiation
are not clear. In this dissertation, different sizes of micro-, submicro-, and nano-pattern platforms
will be designed, fabricated, and evaluated for their capacity to stimulate neural differentiation,
neurite outgrowth, and synaptogenesis.
During development, the ESCs live in a complex micro-environment in vivo. The microenvironment includes topographical information, physiological cues, soluble factors, and cell-cell
interactions. The micro-, submicro-, and nano-pattern topography of the micro-environment play
a vital role in the ESC growth, proliferate, development, and differentiation in vivo (Govey et al.,
2013; Keung et al., 2010; Lapointe et al., 2013). To mimic the topography of the micro-
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environment, different types of biomaterials have been used for the ESC in vitro culturing. These
biomaterials can be divided into fiber, groove, gel, pore, and tube by their 3D shape (Cheng and
Kisaalita, 2010; Gu et al., 2016; Onoe et al., 2016; Yang et al., 2017). They also can be divided by
their material type into metal, silicon, gel, polymer (Grossemy et al., 2019; Mantecon-Oria et al.,
2020; Yan et al., 2017).
The different shapes, properties, and functions of biomaterial platforms have been
designed, fabricated, and applied in cell biological research, tissue assembly, and tissue
implantation (Aamodt and Grainger, 2016; Chew and Danti, 2017; Gao et al., 2019). This
dissertation aims to study the micro-, submicro-, and nano-pattern topography-induced neural
differentiation and maturation. To achieve the aims, the biomaterial used in this dissertation
needs to have the following properties: (1) The biomaterial needs to be approved by the Food
and Drug Administration (FDA), which can be used in tissue implantation; (2) The material needs
to have good biocompatibility, which is not toxic for the cell and tissue culture; (3) The material
needs to be biodegradable, but stable during the experiment and degraded after implantation;
(4) The materials need to be plastic, in which the shape and size of the materials are controllable
in the micro-, submicro-, and nano-level.
Significance for cell biology and cell replacement
Biomaterial platforms are widely used and studied in stem cell research. For example, a
bio-platform could be used to maintain stem cells in the undifferentiated stage in vitro (Fisher et
al., 2010). The bio-platform has also been used to stimulate the cardiomyocytes, neurons, and
epidermis cells regeneration (Haldar et al., 2019; Kim et al., 2014; Yeung et al., 2019). The bioplatform was also used in a cell-matrix interaction study and matrix-induced intracellular
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pathway research (Bax et al., 2019; Cha et al., 2017). The designed, fabricated, and evaluated
micro-, submicro-, and nano-pattern platforms will open a new field of stem cell research in
neural regeneration.
The stem cell and biomaterial studies have been applied mainly to cell replacement
therapy (Bhardwaj et al., 2017; Gao et al., 2018; Huang and Zhang, 2019; Mead et al., 2015). In
this dissertation, the biomaterial-induced neural regeneration method will be studied as it may
provide a suitable approach to alleviate native neuron injury of the peripheral nerves system
(PNS) and central nerves system (CNS) (Figure 6). Stem cells are a suitable cell source for neuronal
Figure 6. Diagram of expected
application of the ESNs with
bio-platform. The NBs were
attached and differentiated on
the bio-platform, which would
form several ESNs on the bioplatform. The combination of
ESNs and biomaterial platform
could be used in the
replacement of damaged spiral
ganglion neurons (SGN) of the
PNS and damaged neurons of
the CNS.

degeneration diseases, such as cardiovascular (ischemic heart disease and heart failure) and
respiratory nerve systems (acute respiratory distress syndrome) recovery (Bagno et al., 2018;
Lanzoni et al., 2021). The bio-platform will stimulate stem cell differentiation, growth and
migration in vitro (Dietrich et al., 2018; Lv et al., 2017; Mashinchian et al., 2015). Stem cell
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injections always result in a large amount of cell loss and off-target effects. Combining stem cells
and biomaterials will improve cell viability and anchoring after the implantation in vivo (Ashe et
al., 2020; Leach et al., 2019).
Application in the injured PNS: SGN damage-induced hearing loss
Hearing loss, which is known as hearing impairment, is the primary disability affecting
approximately 10%- 15% of the population in the world (Belzner and Seal, 2009). The main
symptom of hearing loss is a partial or total inability to hear. Hearing loss may happen at all stages
of life. For newborn children, it is reported that 0.2%- 0.3% of children have profound hearing
loss. The hearing loss that happens in this stage will influence severe consequences for children,
such as the risk for irreversible speech, language, and cognitive deficits (Lieu et al., 2020). For
adults (26- 69 years old), it is reported that 26 million (15%) of Americans have a high-frequency
hearing loss. For the senior adults (65-74 years old and older than 74 years old), there are 30%
(65-74 years old) and 47% (older than 74 years old) of Americans have impaired hearing. Hearing
loss in adults induces loss of educational and employment opportunities, social withdrawal, and
emotional problems (anxiety, etc.) (Contrera et al., 2016; Michels et al., 2019).
Hearing loss is usually caused by many factors, including exposure to loud sounds, noise
at work, trauma, ototoxicity (overdose the ototoxic medications, such as aspirin, ibuprofen, and
naproxen), aging, ear infections, developmental deficiency (Cohen et al., 2014; Mulwafu et al.,
2016). Hearing loss is divided into three major types: conductive hearing loss, sensorineural
hearing loss, and mixed hearing loss. Spiral ganglion neuron (SGN) damage-induced hearing loss,
which is sensorineural hearing loss, is caused by SGN damage and degeneration (Epstein and
Reilly, 1989; Kuhn et al., 2011). Spiral ganglion neurons play a vital role in the auditory signal
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transmission pathway (Carricondo and Romero-Gomez, 2019). Spiral ganglion neurons are the
“bridge” cells that connect and transmit the electrical signal between the hair cells and CNs.
Partial or total damage of the SGNs will break the connections and inhibit or block the auditory
pathway, respectively, which will cause sensorineural hearing loss. As the generation of SGNs
only happens during early mammalian stages (embryo day 8 to postnatal day 28 of mouse), they
cannot regenerate in vivo to cure the damaged cells. In other words, the SGN-damaged induced
hearing loss is irreversible.
Our previous report showed that the newly generated ESNs could be the potential source
of cells to replace the damaged SGN (Liu et al., 2018b). The ESNs can grow and differentiate on
our newly designed bio-platform to get native bungee-like (highly parallel) and mature neurons
(Liu and Hu, 2018). Combining the ESNs and bio-platform can be used in SGN replacement
research and therapy in the future.
Application in the CNS injured: Central nervous system disease
Besides application to PNS nerve injury, the ESNs and the bio-platform system can also
contribute to treatment of CNS diseases (Ashammakhi et al., 2019; Lim and Spector, 2017). CNS
diseases or disorders are caused by damage of the central nerve (Cacabelos et al., 2016). These
damages will affect the structure or function of the spinal cord or brain. The main signs and
symptoms are loss of feeling, memory loss, tremors, slurred speech. The representative diseases
are Alzheimer, Huntington, Parkinson. Many groups are currently studying bio-platform-induced
cell implantation to treat spinal cord damaged. The microfiber platform can restore the damaged
spinal cord by implantation with stem cell-derived neurons (Grijalvo et al., 2019). The study and
usage of biomaterials will open a new avenue in CNS disease therapy.
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Aims of dissertation research
Based on these new neural differentiation methods and novel findings of biomaterials,
the central hypothesis to be investigated in this dissertation research is that a submicron fiber
substrate can stimulate ESC-derived neural differentiation and maturation in vitro. There are
three integrative specific aims pursued (Figure 7):

Figure 7. Road map of the specific aims. Aim 1: Fabricate the submicron fiber substrate and
determine its physical, chemical, and biological properties; Aim 2: determines whether
submicron fiber substrates stimulate ESN differentiation and maturation in vitro via the adhesion
molecule-cytoskeleton signaling pathway; Aim 3: determines whether submicron fiber substrates
can stimulate the synaptogenesis between ESNs and native CN neurons by purified TSP1 protein
incorporated in the substrates.
Aim 1 is to Fabricate the submicron fiber substrate and determine its physical, chemical,
and biological properties. We hypothesize that a submicron fiber substrate can be fabricated and
used in the stem cell culture. The novel submicron fiber substrate will be fabricated using the
micro-fluid chip system and electrospinning equipment. The physical, chemical, and biological
properties of the submicron fibers, including diameter, alignment, biocompatibility, and
biodegradability, will be evaluated to determine whether it is a suitable substrate for stem cell
growth and differentiation.
Aim 2 will determine whether submicron fiber substrates stimulate ESN differentiation
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and maturation in vitro via the adhesion molecule-cytoskeleton signaling pathway. We
hypothesize that the submicron fiber substrate can induce ESN differentiation and maturation
via the integrin receptor. ESNs will be cultured on the submicron fiber substrates, followed by
evaluating neural differentiation and neurite outgrowth by immunostaining assays. Additionally,
integrin receptors will be knocked down by short hairpin RNA (shRNA) technology to elucidate
whether it is the critical receptor to sense the extracellular matrix signaling.
Aim 3 will determine whether submicron fiber substrates can stimulate the
synaptogenesis between ESNs and native cochlear nuclei (CN) neurons by purified
thrombospondin 1 (TSP1) protein incorporated in the substrates. Our previous reported that the
TSP1 was a key protein which could stimulate the synaptogenesis between the ESNs and CNs in
vitro culture (Liu et al., 2018b). Herein, we hypothesize that submicron fiber substrates
incorporated with purified TSP1 protein can stimulate synaptogenesis between ESNs and native
CN neurons. The purified TSP1 protein will be incorporated into the fiber substrates, which will
be released into the culture medium in the co-culture containing ESNs and native CN neurons.
The synaptogenesis between ESNs and native CN neurons will be evaluated using
immunofluorescence to determine the role of released TSP1 in synaptogenesis.
In summary, this dissertation studies the role of submicron fiber substrates in
differentiation, maturation, and synapse formation of stem cell-derived neurons, which provides
a critical step for the integration of newly generated neurons into the native auditory system to
rebuild the acoustic circuit in vitro. The success of this research will suggest the possibility of
developing novel strategies to utilize ESC-derived neurons to treat hearing loss and other
neurodegenerative diseases.
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CHAPTER 2 – DESIGNING, FABRICATING, AND EVALUATING THE ACMFP AND ASMFP
(This chapter contains previously published material. See Appendix B.)
Abstract
A fiber platform is needed to study topography-induced neural differentiation and growth
in vitro. To achieve this aim, the aligned contiguous microfiber platform (ACMFP) and aligned
sub-micro-fiber platform (ASMFP) were designed and fabricated to mimic different sizes (micro-,
submicro-, and nano-level) of the curved topography for the neural differentiation of the ESCs.
To mimic the micro-level topography, the biocompatible and biodegradable PLGA (poly (lacticco-glycolic acid)) material was used to fabricate the ACMFP. The micro-fluid chip-based system
was established and updated to achieve the different aligned and contiguous fiber platforms. To
prevent the shrinkage of the ACMFP, the Pluronic-F127 was applied to the ACMFP treatment.
The result showed that the 60 μm, 90 μm, and 120 μm ACMFP was fabricated. All showed high
alignment and contiguousness. With the treatment of the Pluronic-F127, the ACMFP was kept in
a stable structure for 12 days. The cell viability staining assays indicated that the ACMFP was a
biocompatible platform for cell biology research. To mimic the submicron- and nano-level
topography, the biocompatible PCL(polycaprolactone) material was used to fabricate the ASMFP.
The electrospinning system was used to fabricate the different sizes of the aligned fiber platform.
The result showed that 0.7 μm, 1.5 μm, and 3 μm ASMFP were fabricated. All of them showed
good alignment. The hydrophilicity assay and cell viability assay indicated that the coated ASMFP
had good hydrophilicity and biocompatibility. The ACMFP and ASMFP provide novel platforms
which can mimic the micro-, submicro-, and nano-level topography in vitro. Their application can
contribute to topography-induced cell biology research and other biomaterials substrate-based
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clinical therapy.
Overview of the fiber platform
Biomaterial, which has a fiber-like structure, is widely used in cell biology research and
clinical therapy. Different sizes, types, and protein-treated fiber platforms were designed,
fabricated, and used in the research (Ong et al., 2018; Saveh-Shemshaki et al., 2019). For example,
solid nano-fiber was used to stimulate stem cell differentiation in vitro (Silantyeva et al., 2018).
The submicro-fiber was used to guide neuron growth (Kim et al., 2006). The hollow microfiber
was used to rebuild the nerve tissue in vitro for spinal cord damage therapy (Golafshan et al.,
2018; Morelli et al., 2021). In this dissertation, we mainly focus on fiber-like topography to induce
stem cell fate. Different sizes of the fiber platforms were needed to be designed, fabricated, and
evaluated. The size range for the fiber platform is from the micro-level to the nano-level. As the
limitation about the fiber material and fabricated method, two fiber platforms were designed
separately to achieve these aims, which were poly (lactic-co-glycolic acid) (PLGA)-based ACMFP
(micro-level) and polycaprolactone (PCL)-based ASMFP (submicro- and nano-level).
PLGA for the ACMFP
To study the role of the micro-topography in the stem cell differentiation, an aligned and
contiguous micro-pattern platform was needed. PLGA, a co-polymer material, was chosen as a
biomaterial to fabricate the platform, as its multiply advantages (Astete and Sabliov, 2006;
Kapoor et al., 2015). Firstly, the PLGA has good biocompatibility approved by the FDA for research
and clinical usage (Zheng et al., 2018a). In addition, PLGA has little to no toxicity in cell culture
and implantation (Chen et al., 2020a; Zheng et al., 2018a). Secondly, the PLGA is a biodegradable
material (Du et al., 2020). It can degrade and disappear gradually in vivo and in vitro. The
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degraded material of PLGA also shows good biocompatibility and metabolically (absorption and
metabolism by organism) in vivo. The biodegradation speed is determined by its molecular
weight. The biodegradation speed of PLGA, which is used in this dissertation, is 2-3 months, which
does not influence the research in vitro. Lastly, the PLGA is plastic. It can be shaped into different
structures, such as membrane, fiber, porous, tube (Lai et al., 2019; Sitt et al., 2016; Wang et al.,
2019; Zheng et al., 2018b). However, the PLGA also has a disadvantage that will influence the
micro-topography induced research. It is reported that PLGA fiber materials can shrink during in
vitro culturing (Liu et al., 2018a). The reason is that the glass transition temperature (threshold
temperature at which a material changes from plastic phase to glass) of the PLGA is 45-55°C,
which is close to the cell culture (37°C). This low-temperature environment of the PLGA will keep
the material in the plastic stage. The plastic stage of PLGA easily changes the shape and shrink
spontaneously. To overcome this weakness, a method was needed to over-heat the PLGA fiber
above the transaction temperature to change it into the glass stage, which can help PLGA fiber
maintain a stable structure.
Micro-fluid chip-based system for the ACMFP
To fabricate the micro-pattern platform, many systems have been used widely. Microgroove molds were used to fabricate the polydimethylsiloxane (PDMS) groove platform (Yang et
al., 2017). The micro-fluid chip-based system was used to fabricate the micro-fiber (size range
from 30 μm to 300 μm) (Hwang et al., 2008). In the micro-fluid chip-based system, the PLGADMSO solution was mixed and pumped into the chip as a micro-fluid flow. This flow would
combine with the water solution in the chip. The PLGA was solidified and moved out of the chip
as a fiber-like structure via the flow of PLGA solution and water solution. The different sizes of
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the PLGA micro-fiber fiber can be fabricated by changing the PLGA solution and water solution
flow rate. In this chapter, an updated micro-fluid chip-based system was used to fabricate the
ACMFP.
PCL for the ASMFP
To study the role of submicro- and nano-topography in the stem cell differentiation, an
aligned submicro-pattern platform was needed. The PLGA-based ASMFP showed that PLGA was
not suitable for the submicro-level fiber platform fabrication as its fibers would break or degrade
completely into small fragments in 37°C (Figure 8). To overcome this weakness, material
(Goodwin et al., 2018; Vivi et al., 2019). In other words, it degrades little by little in cells and
Figure 8. PLGA based nano-fiber
with
the
Pluronic
F127
treatment. PLGA was used to
fabricate the nano-fiber platform
by electrospinning system. The
nano-fiber
platforms
were
fabricated in (A) and (C) at room
temperature. All the platforms
showed a fiber-like structure.
After the platforms were
incubated at 37 °C for 24 hours,
the fiber structure of the control
(B) and Pluronic F127 (D) treated
groups disappeared, which
indicated that
PLGA-based
nanofiber was hard to keep
nano-fiber structure in 37 °C by
the anti-shrinkage solution
treatment. The data is collected
using ASMFP produced by the
same batch of the PCL solution.
Scale bar is 10 μm in D.
another polymer, PCL, was used to fabricate the ASMFP. PCL has lots of advantages to fabricate
the ASMFP. Firstly, the PCL has good biocompatibility, which means that it is not toxic to the
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tissues (Feng et al., 2019; O'Leary et al., 2020). Secondly, the PCL is a biodegradable vivo and in
vitro. The biodegradation speed is determined by its molecular weight. Thirdly, the PCL is a plastic
material too. It can be shaped into different kinds of structures (Chen et al., 2020b; Mo et al.,
2006; Xu et al., 2018). Lastly, unlike the PLGA, the PCL has a low glass transition temperature (60°C), which means that it will maintain in the stable glass stage after fabrication. In other words,
it will not shrink in the 37°C. However, the PCL is a hydrophobic material that limits cell
attachment and growth (Moran et al., 2019; Narayanan et al., 2018; Zhang et al., 2016). To
overcome this weakness, a hydrophilic protein-coated method was used and evaluated in this
dissertation.
Electrospinning system for the ASMFP
As the micro-fluid chip-based system only can fabricate a micro-level fiber, a nano-fiber
fabrication system was needed for this dissertation. Electrospinning systems have been used
widely to fabricate the submicro- and nano-level fibers (Bhardwaj and Kundu, 2010). The polymer
solution is loaded with a high voltage (more than 8kV) in the electrospinning system. The polymer
solidifies and changes into the submicro- and nano-level fiber-like structure in the
electrospinning system. These newly generated fibers will attach to the collection unit, which
loads with negative voltage. To create the aligned fiber platform, a rotating metal wheel was used
to collect the fiber. The rotation speed of the wheel will determine the alignment value of the
fiber platform. In addition to changing the other parameters in the system, such as micro-fluid
rate, spin distance, loaded voltage, fiber platforms with different sizes were fabricated. In this
dissertation, this universal electrospinning system was used to fabricate the ASMFP.
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Rationale and hypothesis for Chapter 2
An aligned biomaterial-based platform was needed to apply and study the topographyinduced neural differentiation. To mimic the micro-level topography, a novel platform was
supposed to design and fabricate in the updated micro-fluid chip-based systems to mimic the
micro-level topography. The ACMFP’s physical, chemical, and biological properties would be
tested, such as fiber size, alignment level, plastic, and biocompatibility. To mimic the submicroand nano-level topography, a novel platform was supposed to design and fabricate in the
electrospinning systems. Similar to the ACMFP, the ASMFP’s physical, chemical, and biological
properties would be tested. The chemical treatment method would be used to overcome the
weakness of this platform.
Materials and Methods
Design of the ACMFP
A novel micro-fiber platform was needed to study the micro-pattern platform's role in
stem cell differentiation. To achieve this aim, the ACMFP was designed, as shown in Figure 9.

Figure 9. Designed diagram of the ACMFP. The ASMFP was designed as a platform which
established by parallel (the angle between fibers were less than 10 °C) micro-fibers. These fibers,
which sizes were 30- 300 μm, were fully covered the surface and show no gaps between fibers
to support a fiber-like topography for the further neural differentiation experiment with cell type
evaluation.
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Firstly, the ACMFP was established with one layer of parallel micro-fibers. These fibers were
contiguous and parallel, which avoided the gaps between the fibers and showed high aligned
structure. In addition, the micro-fibers diameter needed to be controllable, which was used to
study the range of the functional fiber size.
ACMFP equipment set up and fabrication
The ACMFP equipment (Figure 10) was set up and updated based on the previous
Figure 10. Updated micro-fluid chip-based
system for the ACMFP fabrication. (A) Diagram
of the updated micro-fluid chip-based system.
The core solution and sheath solution were
pumped as the micro-fluid into the chip. PLGA
of the core solution was solidified when met
with the sheath solution and pumped out the
chip as a fiber-like structure. The collecting part
collected the fiber into the alignment and
contiguous structure by rotation and
movement. (B) Overview of the equipment,
which included the fabrication unit (red box),
chip (green box), and collection unit (blue box).
(C) Overview of the chip, which was inserted
with two solution glass pipettes. Images
obtained by Z Liu and published in Liu and
colleagues, 2018 (Liu and Hu, 2018).
reports (Liu and Hu, 2018). The equipment included two parts, the fabrication part and the
collection part. Two 10 mL syringes and 18 G needles were loaded on two micro-fluid pumps
separately in the fabrication part. The glass pipe connected with one pump was inserted into the
self-made PDMS fabrication chip. The other glass pipe with a puller connected with the other
pump was inserted into the output tube of the chip. The glass pipe injected the sheath solution
(50% Glycerol in distilled water; St. Louis, MO, Sigma) into the chip, while the glass pipe with a
puller injected the core solution (10% PLGA 75:25 in dimethyl sulfoxide DMSO; Sigma) into the
chip. When these two solutions combined, the PLGA began to solidify. The solidified PLGA formed
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the micro-level fiber and was moved out of the chip by the output tube due to the micro-fluid
pumping action. The flow rate of the two solutions controlled the size of the output PLGA fiber.
To obtain fibers with diameters of from 60 to 120 μm, the core solution’s and the sheath
solution’s flow rate were set up at 15-30 μL/min and 500 μL/min respectively. A third microfluid
pump with a rotary motor was added to the equipment for the no-gap fiber collection in the
collection step. The collected coverslip was loaded on the rotary motor, which was linked to the
microfluid pump. The coverslip was rotated at 60 rpm and moved backward with the 40-200
μL/min fluid rate. The output microfiber was attached and rotated in the coverslips to form the
no-gap and no-overlap fiber matrix. After collection, the ACMFP samples were rinsed with
distilled water for 3 hours to remove the residual reagent (glycerol, water, and dimethyl
sulfoxide).
To study the functional size range for the fibers, different sizes of the ACMFP needed to
be fabricated. In the micro-fluid chip-based system, many parameters are controllable to
generate the different sizes of the ACMFP. Table 1 showed the controllable parameters in this
system, including core solution flow rate, sheath solution flow rate, rotation of the collection
motor, and collection motor moving speed. By testing, this system can generate fibers with
diameters from 30 μm to 300 μm. Three different fibers were chosen to study in this dissertation,
which was 60 μm, 90 μm, and 120 μm. The detailed system parameters which used to fabricate
three different sizes of ACMFPs were listed in the Table 1. The 60 μm ACMFP was fabricated with
the 15 μL/min core solution flow rate and 40 μL/min collected pump moving speed. The 90 μm
ACMFP was fabricated with the 20 μL/min core solution flow rate and 100 μL/min collected pump
moving speed. The 120 μm ACMFP was fabricated with the 28 μL/min core solution flow rate and
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200 μL/min collected pump moving speed.
Table 1. System parameters for the ACMFPs fabrication
Expected ACMFP
fiber diameter (μm)

Core solution
flow rate
(μL/min)

Sheath solution flow Rotation of the
rate (μL/min)
collection motor
(rpm)

Collection motor
move speed
(μL/min)

60

15

500

60

40

90

20

500

60

100

120

28

500

60

200

PLGA flat membrane fabrication
A coverslip was designed as a mold to fabricate the PLGA flat membrane (mimic the flat
topography, used as a control platform to evaluate the function of the micro-fiber topography in
neural differentiation). 10% PLGA of DMSO solution was poured into the chamber. The solution
was dried at room temperature overnight, following by 3 hours of distilled water rinsing to
remove the residual reagent (DMSO). The PLGA flat membrane was out of the mold and cut into
the proper size for the following experiments listed below.
ACMFP shrinkage assay
PLGA was in the unstable stage at 37 °C. This unstable stage of PLGA may leaded to the
shape-changing and diameter shrinkage of ACMFP. Thus, the shrinkage of the ACMFP needed to
be evaluated and improved here. The ACMFP was treated with 40% (m/v) Pluronic F127 solution
(St. Louis, MO, Sigma) at 4 °C overnight (Figure 11). The ACMFP with Pluronic F127 solution was
placed into the 70 °C incubators for 3 hours. After the solution was converted into the solid stage,
the ACMFP was rinsed with ice-cold distilled water until the residual reagents (Pluronic F127)
were removed. The Pluronic F127 treated and non-treated ACMFPs were sterilized with 70%
alcohol for 15 minutes, followed by phosphate-buffered saline (PBS) 3-5 times rinsing. The
ACMFPs were stored in the PBS in a 37 °C and 5% CO2 incubator for 9 days. The ACMFPs were
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imaged by the microscope every day (day 0 to day 12) to evaluate the shrinkage condition (the
significant reduction of the fiber diameter was considered as shrinkage).

Figure 11. Diagram of the fiber shrinkage assay. The ACMFPs were rinsed and sterilized at room
temperature. In the first three days, part of the ACMFPs was treated with Pluronic F127, while
the left ACMFPs were treated with PBS as control. Two groups of the ACMFPs were incubated in
the 37°C and 5% CO2 incubator for 9 days. All the ACMFPs were imaged and evaluated the fiber
diameter and alignment value every two days, which was used to evaluate the shrinkage
condition of the ACMFPs.
ACMFP biocompatibility assay
PLGA is a biocompatible material. However, the biocompatibility of the ACMFP is unclear,
which is dissolved in DMSO solution and treated with Pluronic F127. The ACMFPs were sterilized
with 70% alcohol for 15 minutes, followed by PBS 3-time rinsing. Next, the ACMFPs were coated
with 0.1% Embryo-Max-Gelatin (Carlsbad, CA, Invitrogen) for 30 minutes and pre-treated with
10% coverslip medium in the 37 °C and 5% CO2 incubator for 30 minutes. HEK 293 cells (universal
cell line for the biocompatibility evaluation (Pospisil et al., 2016; Sun et al., 2014; Zhang et al.,
2019)) were seeded on the ACMFPs and cultured with the 293T culture medium in 37°C and 5%
CO2 incubator. After 24 hours, the samples were stained with the Calcein (1:2000; live-cell
marker), PI (Propidium Iodide; 1:2000; dead cell marker), and H33342 (1:3000; cell nuclei marker;
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Invitrogen) in the 37 °C and 5% CO2 incubator for 20 minutes (Figure 12). The samples were
observed and imaged by Leica DMI 3000B epifluorescence microscopy. The positive signal of the
Calcein, PI, and H33342 were showed in each channel of the microscopy images. The cells which
doubled labeled with the Caclein and H33342 indicated that they are live cells, while the cells
double-labeled with the PI and H33342 indicated that they are dead cells. The percentage of the
live cells and dead cells were used to evaluate the biocompatibility of the ACMFP.

Figure 12. Diagram of the fiber biocompatibility assay. The 293T cells were seeded on the
ACMFPs. After 24 hours cultured, the samples were stain with H33342 (blue, cell nuclei marker),
Calcein (green, live-cell marker), and PI (Propidium Iodide; red, dead cell marker). The cell viability
condition (percentage of the live & died cell) on the ACMFPs were used to evaluate the
biocompatibility of the ACMFP.
Design of the ASMFP
To study the role of the submicro- and nano-pattern platform in stem cell differentiation,
a novel submicro-fiber platform was needed. To achieve this aim, the ASMFP was designed, as
shown in Figure 13. The ACMFP was established with multi-layers of parallel submicro-fibers.
These fibers were parallel and fully covered by multi-layers which avoided the blank area
between the fibers and showed a good-aligned structure. In addition, the submicro-fibers’
diameter needed to be controllable, which was used to study the range of the functional fiber
size.
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Figure 13. Design diagram of the ASMFP. The ASMFP was designed as a platform which
established by parallel (the angle between fibers were less than 10 °C) submicro- or nano-fibers.
These fibers, which sizes were 0.7- 3 μm, were fully covered the surface to support a fiber-like
topography for the further neural differentiation experiment with cell type evaluation.
ASMFP equipment and fabrication
A standard electrospinning system (Figure 14; China, Tong Li Tech Co) was set up and
calibrated as previous reports (Xue et al., 2019; Zhang et al., 2017). The PCL powder (St. Louis,
MO, Sigma) was dissolved into the Chloroform /THF solution (3:1; St. Louis, MO, Sigma), with a
final concentration of 30% (m/v). The 30% PCL was kept at room temperature for 24 hours to
ensure all the PCL was solved. The PCL solution was loaded into the micro-fluid pump. The pump
injected the solution into the electrospinning system with a fixed fluid rate (0.8 mL/h). The high
voltage (8-25kV) was load into the system. The PCL solution pump needle in the electrospinning
system moved from the left side to the right side at a fixed speed (2cm/s) to prevent the
asymmetric thickness of the platform. The PCL fibers were pumped out of the needle and
attached to the rotating metal collecting wheel, which was negatively charged. The wheel rotated
at a fixed speed (2000 rpm) to ensure the fibers aligned well on the collecting wheel. After
fabrication and collection, the ASMFP was rinsed with distilled water for 3 hours to remove the
residual reagent (Chloroform and THF).
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Figure 14. Electrospinning system for ASMFP fabrication. (A) Diagram of the electrospinning
system for ASMFP fabrication. 30% PCL was loaded into the micro-fluid pump. The pump injected
the solution into the electrospinning system with a fixed fluid rate (0.8 mL/h). The high voltage
(8-25kV) was load into the system. The PCL solution pump needle in the electrospinning system
moved from the left side to the right side at a fixed speed (2cm/s) to prevent the asymmetric
thickness of the platform. The PCL fibers were pumped out of the needle and attached to the
rotating metal collecting wheel, which was negatively charged. The wheel rotated at a fixed
speed (2000 rpm) to ensure the fibers aligned well on the collecting wheel. (B) Overview of the
electrospinning system from Tong Li Tech Co, China. (C) The fabrication unit (red arrow with a
positive charge) and collecting wheel unit (blue arrow with a negative charge) in the
electrospinning system. Electro spun system images were taken in Dr. Hu’s Stem Cell Research
Lab in the Department of Otolaryngology-HNS (Photo courtesy of Zhenjie Liu).
To study the functional size range for the fibers, the different sizes of the ASMFP needed
to be fabricated. In the electrospinning system, many parameters are controllable to generate
the different sizes of the ASMFP. Table 2 showed the controllable parameters in this system,
including load voltage, spin distance, collector rotation speed, solution flow rate, and needle
move speed. By testing, this system can generate fibers which diameter is from 0.7 μm to 3 μm.
Three different fibers were chosen to study in this dissertation, which were 0.7 μm, 1.5 μm, and
3 μm. The detailed system parameters which used to fabricate three different sizes of ACMFPs
were listed in the Table 2. The 0.7 μm ASMFP was fabricated with the 25kV load voltage and 12
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cm spin distance. The 1.5 μm ASMFP was fabricated with the 15kV load voltage and 9 cm spin
distance. The 3 μm ASMFP was fabricated with the 8kV load voltage and 6 cm spin distance.
Table 2. System parameters for the ASMFP fabrication
Expected ASMFP
fiber diameter
(μm)

Voltage of
positive pole
(kV)

Voltage of
negative
pole (kV)

Spin
distance
(cm)

Collector
rotation
speed
(rpm)

PCL flow
rate (mL/h)

Needle
move
speed
(cm/s)

0.7

25

-2

12

2000

0.8

2

1.5

15

-2

9

2000

0.8

2

3

8

-2

6

2000

0.8

2

PCL flat membrane fabrication
To fabricate the PCL flat membrane (control), a glass coverslip was used. 30% PCL of
Chloroform/THF solution was poured on this glass coverslip. The solution was dried at room
temperature overnight, following by 3 hours of distilled water rinsing to remove the residual
reagent. The PCL flat membrane was moved off from the glass coverslip and cut into the proper
size for the following experiments.
ASMFP hydrophilicity assay
PCL is a hydrophobic material, which limits cell attachment and growth (Shen et al., 2011).
The chemical treatment method was needed to improve the ASMFP surface hydrophilicity. The
ASMFPs were treated with Poly-D-Lysine (PDL) solution (Carlsbad, CA, Invitrogen) for 4 hours and
treated with Poly-L-ornithine (PLO) solution (Invitrogen) for another 12 hours in 37°C. After
treatment, the ASMFP was rinsed with PBS to remove the residual reagent (PDL and PLO). The
hydrophilicity assay was processed in the treated and non-treated (control) ASMFPs to identify
the material property as the previous report (Thomas et al., 2014; Zhao et al., 2015)(Figure 15).
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40 μL distilled water was dripped on all groups of ASMFPs. The angle of the corner between the
water droplet and substrate was used to evaluate the material hydrophilicity. When the angle is
less than 90°C (acute angle), the material is hydrophilicity. When the angle is more than 90°C
(obtuse angle), the material is hydrophobic.

Figure 15. Diagram for the ASMFP hydrophilicity assay. To test the hydrophilic of the platform,
40 μL distilled water was dripped on PDL/PLO treated ASMFPs and control. The angle of the
corner between the water droplet and substrate was used to evaluate the material hydrophilicity.
When the angle is less than 90°C (acute angle), the material is hydrophilicity. When the angle is
more than 90°C (obtuse angle), the material is hydrophobic.
ASMFP biocompatibility assay
PCL is a biocompatibility material. However, the biocompatibility of the ASMFP is not clear,
which it suffered from Chloroform/THF solution and PDL/PLO treatment. To evaluate the
biocompatibility, three groups of the ASMFPs were sterilized with 70% alcohol for 15 minutes,
following by PBS 3-time rinsing. Next, the ASMFPs were coated with PDL/PLO and pre-treated
with the 10% coverslip medium in the 37 °C and 5% CO2 incubator for 30 minutes. Next, ESNs
were seeded on the ASMFPs and cultured with the 10% coverslip culture medium in 37 °C and 5%
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CO2 incubator. After 24 hours, the samples were stained with the Calcein (1:2000; live-cell
marker), PI (1:2000; dead cell marker), and H33342 (1:300, cell nuclei marker, Carlsbad, CA,
Invitrogen) in the 37 °C and 5% CO2 incubator for 20 minutes. The samples were observed and
imaged by Leica DMI 3000B epifluorescence microscopy. The positive signal of the Calcein, PI,
and H33342 were showed in each channel of the microscopy images. The cells which doubled
labeled with the Calcein and H33342 indicated that they are live cells, while the cells doubled
labeled with the PI and H33342 indicated that they are dead cells. The percentage of the live cells
and dead cells were used to evaluate the biocompatibility of the ASMFP.
Quantification study and statistical analysis
The physical factors of the ACMFPs and ASMFPs were measured and analyzed, which
included their fiber diameter and alignment value. For the diameter evaluation, all fibers in each
ACMFP and ASMFP sample image were selected and measured via the ImageJ software length
tool plugin (the total number of independent measurements between all treatment groups is 18;
ACMFP samples (n) were from 3-6 independent experiments, ASMFP samples (n) were from 3
independent experiments). For the alignment test, the collecting rotator or collecting wheel
rotating direction was chosen as the reference whose alignment value was equal to 0. The
alignment value of each fiber was equal to the angle between the reference and the tested fiber.
The angle was measured via the ImageJ software angle tool plugin (the total number of
independent measurements between all treatment groups is 18; ACMFP samples (n) were from
3-6 independent experiments, ASMFP samples (n) were from 3 independent experiments).
The biocompatibility of the ACMFPs and ASMFPs were evaluated and analyzed. The
positive cells of each protein marker (Calcein and PI) on the ACMFPs and ASMFPs (outcome factor
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to evaluate the biocompatibility) were counted by the cell counter plugin module of Image J
software (NIH). The percentage of the positive cells was equal to the number of Calcein or PI
positive cells over the number of H33342 positive cells (the total number of independent
measurements between all treatment groups is 3, ACMFP samples (n) were from 3 independent
experiments; the total number of independent measurements between all treatment groups is
3, ASMFP samples (n) were from 3 independent experiments).
The hydrophilicity of the ASMFPs was evaluated and analyzed. The angle between the
water droplet and platform in all ASMFPs groups was measured via the ImageJ software angle
tool plugin (the total number of independent measurements between all treatment groups is 6,
ASMFP samples (n) were from 3 independent experiments).
As mentioned in the previous parts separately, all the samples were collected from 3-6
independent experiments. Each independent experiment indicated the repeated experiment
with independent platforms and cells. The number of n in each independent experiment means
the number of the independent platforms or culturing wells. For example, “the total number of
independent measurements between all treatment groups is 24 and samples (n) were from 3
independent experiments” indicated that the experiments were repeated 3 times with same
protocol in different day. In each experiment, there were 8 separate samples in each group. A
total 24 (3 x 8) experiments were used for the quantification study and statistical evaluation.
The data are represented as mean ± standard deviation. Student’s t-test, a one-way
ANOVA with post-hoc Tukey HSD Test and a two-way ANOVA test were used for statistical
significance. The actual statistical power was calculated by G*power. The p-values smaller than
0.05 were considered significant (P<0.05, marked with *; P<0.01, marked with ** in the figures).
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Results
Physical evaluation of the ACMFP
The ACMFPs with different diameters were fabricated, which were contiguous as
expected. There were no observed gaps between the fibers (Figure 16). The quantification

Figure 16. Physical factor evaluation of the ACMFP. (A) The bright-field image showed the 60
μm, 90 μm, and 120 μm ACMFPs. There were no observed gaps between the fibers in all three
ACMFPs (B) Quantification studies of the ACMFPs’ fiber diameter. The diameter of the 60 μm,
90 μm, and 120 μm ACMFPs’ fibers were 60.61 ± 0.65 μm, 90.23 ± 1.75 μm, and 121.05 ± 1.23
μm (mean ± standard deviation, the total number of independent measurements between all
treatment groups is 18; ACMFP samples (n) were from 6 independent experiments, (C)
Quantification study of the ACMFPs’ fiber alignment. The alignment values of 60 μm, 90 μm, and
120 μm groups were 1.47 ± 1.43°, 2.15 ± 2.10°, and 3.15 ± 1.79° (mean ± standard deviation, the
total number of independent measurements between all treatment groups is 18; ACMFP samples
(n) were from 6 independent experiments). All of them were smaller than 10° which were
defined as high alignment. There was no significant difference (N.S.) between the 60 μm ACMFP
and 90 μm ACMFP (P=0.28, actual statistical power= 0.80, Student’s t-test) or between 90 μm
ACMFP and 120 μm ACMFP (P=0.14, actual statistical power= 0.81, Student’s t-test). Scale bar
is 100 μm in A.
studies showed that the diameter of the 60 μm ACMFP’s fiber was 60.61 ± 0.65 μm. The diameter
of the 90 μm ACMFP’s fiber was 90.23 ± 1.75 μm. The 120 μm ACMFP’s fiber diameter was 121.05
± 1.23 μm (mean ± standard deviation, the total number of independent measurements between
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all treatment groups is 18; ACMFP samples (n) were from 6 independent experiments, Figure 16).
The alignment values of 60 μm, 90 μm, and 120 μm groups were 1.47 ± 1.43°, 2.15 ± 2.10°, and
3.15 ± 1.79° (mean ± standard deviation, the total number of independent measurements between
all treatment groups is 18; ACMFP samples (n) were from 6 independent experiments). All of them
were smaller than 10° which were defined as high alignment. The alignment value of the ACMFPs
seemed to increase as their diameter increase. However, there was no significant difference
between the 60 μm ACMFP and 90 μm ACMFP (P=0.28, actual statistical power= 0.80, Student’s
t-test) or between 90 μm ACMFP and 120 μm ACMFP (P=0.14, actual statistical power= 0.81,
Student’s t-test).
Shrinkage evaluation of the ACMFP
As the fiber shrinkage was caused by their material properties, only one group of ACMFP
(90 μm) as a representative was chosen to evaluate the fiber shrinkage (Figure 17). The ACMFP
was incubated from day 0 to day 2 at room temperature with different treatments and incubated
from day 3 to 12 at 37 °C. The condition of the ACMFPs was imaged to analyze the structure
change on day 1, 2, 3, 5, 7, and 12. There was no viewable structural change from day 0 to day 2
in control and Pluronic F127 treated groups. However, the fibers started to shrink, and the
alignment value showed a significant increase from day 3 to day 12. Several gaps were observed
between the fibers during this period (* area in Figure 17). The quantification studies showed
that the fiber of the ACMFPs shrink from 90.58 ± 3.27 μm (Day 2) to 53.05 ± 5.23 μm (Day 12)
little by little after they incubated in the 37°C, which showed a significant decrease (mean ±
standard deviation; P<0.0001, actual statistical power= 0.93, Student’s t-test; the total number of
independent measurements between all treatment groups is 10, samples were (n) from 3
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experiments).
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Figure 17. ACMFP anti-shrinkage evaluation. (A) Bright-field image for the ACMFPs treated and
non-treated with Pluronic F127 from day 0 to day 2 at room temperature and from day 3 to day
12 at 37 °C. The Pluronic F127 treated group was treated with the chemical on day 1. Serval gaps
(marked with red * symbol) were found in the control groups from day 3 to day 12, while there
were no gaps found in all Pluronic F127 treated groups. (B) The quantification study for the fiber
diameter changes in the groups. The diameter of the control groups started to have a significant
decrease from day 3 (mean ± standard deviation; F(6,63)= 230.53, P<0.0001, one-way ANOVA with
post-hoc Tukey HSD Test; the total number of independent measurements between all treatment
groups is 10, samples (n) were from 3 independent experiments), while the diameter of the
Pluronic F127 treated groups did not have a significant difference between day 1 and day 12
(mean ± standard deviation; P=0.41, Student’s t-test; the total number of independent
measurements between all treatment groups is 10, samples (n) were from 3 independent
experiments). (C) The quantification study for the fiber alignment changes in the groups. The
alignment value of the control groups started to have a significant increase from day 3 (mean ±
standard deviation; F(6,63)= 10.00, P<0.0001, ne-way ANOVA with post-hoc Tukey HSD Test; the
total number of independent measurements between all treatment groups is 10, samples were from
3 independent experiments), while the diameter of the Pluronic F127 treated groups did not have
a significant difference between day 1 and day 12 (mean ± standard deviation; P=0.34, Student’s
t-test; the total number of independent measurements between all treatment groups is 10, samples
(n) were from 3 independent experiments). Scale bar is 100 μm in A.
from 1.23 ± 1.27° to 7.92 ± 4.21° from day 2 to day 12, which showed significant different (mean
± standard deviation; P=0.0002, actual statistical power= 0.85, Student’s t-test; the total number
of independent measurements between all treatment groups is 10, samples (n) were from 3
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independent experiments). These results indicated that ACMFP could not maintain a stable
structure in 37°C incubation. To overcome this problem, the Pluronic F127 was used to treat the
ACMFP on day 1. The ACMFPs covered with Pluronic F127 were heated to 70°C for 3 hours,
followed by PBS rinse at 4°C. The treated ACMFPs were incubated at 37°C from day 3 to day 12.
There were no observable gaps found in the AMFSPs. The quantification study showed that the
diameter of the ACMFPs was 91.22 ± 3.22 μm at Day 1, while the diameter of the ACMFPs was
89.93 ± 3.62 μm at Day 12. There was no significant difference between these two time points
(mean ± standard deviation; P=0.41, actual statistical power= 0.81, Student’s t-test; the total
number of independent measurements between all treatment groups is 10, samples (n) were from
3 independent experiments). The alignment value also did not have significant change at Day 1
and Day 12, which were 0.61 ± 0.61° and 0.95 ± 0.94° (mean ± standard deviation; P=0.34, actual
statistical power= 0.80, Student’s t-test; the total number of independent measurements between
all treatment groups is 10, samples (n) were from 3 independent experiments). These results
showed that by treat with the Pluronic F127, the ACMFPs did not shrink during the 37°C
incubation and keep in a stable stage as designed.
Biocompatibility evaluation of the ACMFP
PLGA is a good biocompatibility material (Zheng et al., 2018a). However, the
biocompatibility of the ACMFP is not clear. 293T cells were used to evaluate the ACMFP
biocompatibility as the previous method (Pospisil et al., 2016; Sun et al., 2014; Zhang et al., 2019).
The 293T cells were seeded and cultured on the ACMFP. After two days, the cell viability staining
kit was used on the ACMFP. The fluorescence staining showed that many cells located on the
ACMPF were marked by H33342 (cell nucleus marker) and Calcein (live cell marker). Moreover,
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some cells were marked by PI (dead cell marker). The quantification study showed that 88.46 ±
2.81% cells were marked by Calcein, and 11.54 ± 2.81% cells were marked by PI (mean ± standard
deviation; the total number of independent measurements between all treatment groups is 3,
samples (n) were from 3 independent experiments; Figure 18). The result showed that most of
the cells lived on the ACMFP (more than 80% live cells were considered as noncytotoxicity(Lopez-Garcia et al., 2014)), which indicated that ACMFP is not or less toxic for the
cell. In other words, the PLGA based ACMFP has good biocompatibility.

Figure 18. Cell viability evaluation of the ACMFP. (A) The phase and immunofluorescence images
showed that cells were label by the H33342 (cell nuclei marker), Calcein (live cell marker), and PI
(dead cell marker) on the ACMFPs. (B) The quantification study showed that the percentage of
cells labeled with Calcein and PI on the ACMFPs were 88.46 ± 2.81% and 11.54 ± 2.81% (mean ±
standard deviation; the total number of independent measurements between all treatment
groups is 3, samples (n)were from 3 independent experiments). This figure was published in Liu
and colleagues, 2018 (Liu and Hu, 2018). Scale bar is 100 μm in A.
Physical factor evaluation of the ASMFP (Pilot Data)
The ASMFPs with different diameters were fabricated in different time points, including
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3, 10, 15, 30, and 60 minutes (Figure 19). After 60 minutes of spinning, the fibers covered all the
surface, showing no observed blank in the platform. 60-minute spinning was used in the further

Figure 19. Fabricated ASMFPs in different time points and groups (Pilot data). The ASMFPs with
different diameters were fabricated at different time points, including 3, 10, 15, 30, and 60
minutes. After 30 and 60 minutes of spinning, the fibers covered all the surface, showing no
observed blank in the platform. The data is collected using ASMFP produced by the same batch
of the PCL solution, which showed as the pilot data. Additional experiments are required to
complete the project. Scale bar is 10 mm.
ASMFP fabrication. The three groups of the ASMFP, in which the expected diameter were 0.7 μm,
1.5 μm, and 3 μm, were fabricated as designed. The quantification studies showed that the
diameter of the 0.7 μm ASMFP’s fiber was 0.70 ± 0.06 μm. The diameter of the 1.5 μm ACMFP’s
fiber was 1.52 ± 0.08 μm. The 3 μm ACMFP’s fiber diameter was 3.03 ± 0.23 μm (mean ± standard
deviation; the total number of independent measurements between all treatment groups is 9,
ASMFP samples (n) were from 3 independent experiments; Figure 20). The alignment values of
0.7 μm, 1.5 μm, and 3 μm groups were 6.41 ± 1.00°, 6.69 ± 1.14°, and 8.85 ± 1.59 ° (mean ±
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Figure 20. Physical factor evaluation of the ASMFP (Pilot data). (A) Bright-field images showed
the 0.7 μm, 1.5 μm, and 3 μm ASMFPs present alignment structure after 3-, 10-, and 15-min
spinning. (B) Quantification study of the ACMFPs’ fiber diameter. The diameter of the 0.7 μm, 1.5
μm, and 3 μm ASMFPs’ fibers were 0.70 ± 0.06 μm, 1.52 ± 0.08 μm, and 3.03 ± 0.23 μm (mean ±
standard deviation, the total number of independent measurements between all treatment
groups is 9; ASMFP samples (n) were from 3 independent experiments, (C) Quantification study
of the ASMFPs’ fiber alignment. The alignment values of 0.7 μm, 1.5 μm, and 3 μm groups were
6.41 ± 1.00°, 6.69 ± 1.14°, and 8.85 ± 1.59° (mean ± standard deviation, the total number of
independent measurements between all treatment groups is 9; ASMFP samples (n) were from 3
independent experiments). All of them were smaller than 15° which showed good alignment.
The alignment value of the 3 μm ASMFP group was significantly higher than the other two groups
(F(2,24)= 9.95, P=0.0007, one-way ANOVA with post-hoc Tukey HSD Test; the total number of
independent measurements between all treatment groups is 9, samples (n) were from 3
independent experiments). The data is collected using ASMFP produced by the same batch of the
PCL solution. Additional experiments are required to complete the project. Scale bar is 10 μm in
A.
standard deviation; the total number of independent measurements between all treatment groups
is 9, ASMFP samples (n) were from 3 independent experiments). All of them were smaller than
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15° which were considered as good alignment. 1.5 μm and 3 μm ASMFP’s alignment value
showed significant increase than 0.7 μm one (F (2,24)= 9.95, P=0.0007, actual statistical power=
0.86, one-way ANOVA with post-hoc Tukey HSD Test; the total number of independent
measurements between all treatment groups is 9, samples (n) were from 3 independent
experiments). The data is collected using ASMFP produced by the same batch of the PCL solution,
which showed as a pilot data. Additional experiments are required to complete the project.
Hydrophilic evaluation of the ASMFP (Pilot Data)
The hydrophilic of the platform plays a crucial role in cell attachment and growth (Shen
et al., 2011). To achieve this aim, the ASMFPs need to be a hydrophilic platform for stem cell
research. To check the ASMFPs’ hydrophilic, the standard hydrophilic assay was used in this
dissertation as the previous report (Thomas et al., 2014; Zhao et al., 2015). The result showed
that the three ASMFP groups' hydrophilic angles were much larger than the right-angle, which
suggested the surfaces were hydrophobic (Figure 21). To overcome this weakness, a PDL/PLO
Figure 21. Hydrophilic evaluation of the
ASMFP (Pilot data). The image showed the
condition of the water droplet on 0.7 μm,
1.5 μm, and 3 μm ASMFPs with and without
PDL/PLO coated. For the hydrophilic assay,
the angle of the corner between the water
droplet and substrate was used to evaluate
the material hydrophilicity. The angle in 0.7
μm, 1.5 μm, and 3 μm ASMFPs control
groups showed obtuse angle, which
indicated the platforms were hydrophobic.
However, when the in 0.7 μm, 1.5 μm, and
3 μm ASMFPs coated with PDL/PLO, the
angle was acute, indicating the platforms
were hydrophilicity. The data is collected
using ASMFP produced by the same batch
of the PCL solution. Additional experiments
are required to complete the project.
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solution was used to coat the ASMFP. After coated, the water droplet showed a small angle
(smaller than right-angle) between the water drop and three ASMFP groups, which suggested
the surface was changed into hydrophilic.
PCL is a good biocompatibility material (Feng et al., 2019; O'Leary et al., 2020). However,
the biocompatibility of the ASMFP is not clear. The biocompatibility assay was used to test the
ACMFP via ESN cells. The ESN cells were seeded and cultured on the 0.7 μm, 1.5 μm, and 3 μm
ASMFPs. After two days, the cell viability staining kit has treated the cells on the ASMFP. The
fluorescence staining result showed that 97.31 ± 1.12%, 97.42 ± 1.36%, and 97.10 ± 1.86% of cells
located on the 0.7 μm, 1.5 μm, and 3 μm ASMPF were marked by H33342 (cell nucleus marker)
and Calcein (live cell marker) (Figure 22), suggested most of them were the live cells. 2.69 ± 1.12%,
2.58 ± 1.36%, and 2.90 ± 1.86% cells on the 0.7 μm, 1.5 μm, and 3 μm ASMPF were marked by PI
(dead cell marker), suggested fewer cells died on the ASMFPs. Also, there was no significant
difference among the three groups (FR(7,14)= 0.91, P=0.527, FC(2,14)= 0.095, P=0.910, actual
statistical power= 0.80, two-way ANOVA; the total number of independent measurements
between all treatment groups is 8, samples (n) were from 3 independent experiments). The result
indicated that ASMFP is not toxic for the cell. In other words, the PCL-based ASMFP has good
biocompatibility. The data is collected using ASMFP produced by the same batch of the PCL
solution. Additional experiments are required to complete the project.
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Figure 22. Biocompatibility evaluation of the ASMFPs (Pilot data). (A) The immunofluorescence
images showed that cells were label by the H33342 (cell nuclei), Calcein (live cell), and PI (dead cell)
on 0.7 μm, 1.5 μm, and 3 μm ASFMPs. (B) The quantification study showed that the percentage
of cells labeled with Calcein on the 0.7 μm, 1.5 μm, and 3 μm ASMFPs were 97.31 ± 1.12%, 97.42
± 1.36%, and 97.10 ± 1.86% (mean ± standard deviation; n=8, samples were from 3 independent
experiments). (C) The quantification study showed that the percentage of cells were labeled with
Calcein on the 0.7 μm, 1.5 μm, and 3 μm ASMFPs were 2.69 ± 1.12%, 2.58 ± 1.36%, and 2.90 ±
1.86% (mean ± standard deviation; n=8, samples were from 3 independent experiments). There
was no significant difference among the three groups (FR(7,14)= 0.91, P=0.527, FC(2,14)= 0.095,
P=0.910, actual statistical power= 0.80, two-way ANOVA; ; the total number of independent
measurements between all treatment groups is 8, samples (n) were from 3 independent
experiments). The data is collected using ASMFP produced by the same batch of the PCL solution.
Additional experiments are required to complete the project. Scale bar is 20 μm in A.
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Discussion
The purpose of this study was to fabricate the fiber platform to mimic the different sizes
of the topography. During development, the cell lives in a complex micro-environment in vivo.
The micro-environment includes topographical information, physiological cues, soluble factors,
and cell-cell interactions. The micro-, submicro-, and nano-pattern topography of the microenvironment play a vital role in cell growth, proliferation, development, and differentiation in
vivo(Govey et al., 2013; Keung et al., 2010; Lapointe et al., 2013). To mimic the different sizes of
the topography, a novel platform was needed here. The most important findings of the current
study were that two biomaterial-based fiber platforms were designed, fabricated, and evaluated.
To mimic the micro-level fiber topography, ACMFP were designed as contiguous, parallel,
and fiber-based structure. The micro-fluid chip-based system was updated with a collecting unit
to collect the PLGA-based fibers in a platform that kept them parallel and contiguous. As the
plastically of the PLGA fibers, the ACMFP were fabricated into three different sizes, which were
60 μm, 90 μm, and 120 μm. The different sizes of the ACMFP could cover the micro-level fiber
topography for further research. The alignment test and biocompatibility assay were evaluated
for the ACMFP. The results showed that it was a good alignment and not toxic platform for the
cell culture. However, the PLGA fiber showed an unstable stage in the body temperature, which
limited the cell research. Therefore, the Pluronic F127 was treated for the ACMFP. It could help
the ACMFP transfer into the glass stage (stable stage) to avoid shrinking body temperature.
Overall, a good platform that has the micro-level topography was generated.
Besides the study of fiber sizes of ACMFPs, the microfibers' whole and local elasticity may
also be critical physical factors that could influence cell growth and differentiation. However,
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these properties did not evaluate in this dissertation, limiting the study of the other physical
factors' role in cell growth and differentiation. What is more, the different sizes of fibers had
different curvature topography. The specific role of the curvature topography in cell growth and
differentiation was not involved in this dissertation. These factors would be considered and
evaluated in the future with different types of evaluation methods and platforms.
To mimic the submicro- and nano-level fiber topography, ASMFP was designed as a parallel
and fiber-based structure. The electrospinning system was used to fabricate the PCL-based fibers
in a platform that kept them parallel. The long-time fabrication of the fibers (60 minutes) let the
fibers fully cover the whole platform (no blank area). As the plastically of the PCL fibers, the
ACMFP were fabricated into three different sizes, which were 0.7 μm (nano), 1.5 μm (submicron),
and 3 μm (submicron). The different sizes of the ACMFP could cover the nano- and submicrolevel fiber topography for further research. The alignment test and biocompatibility assay were
evaluated for the ASMFP. The results showed it was a good alignment and not toxic for the cell
culture. However, the PCL showed a hydrophobic surface which limited the cell attachment and
growth. The PDL/PLO were used to coat the platforms, which led to the surface change into
hydrophilicity. Overall, a good platform that had nano- and submicro-level topography was
generated.
As the previous hypothesis in this chapter, one platform needed to be designed, fabricated,
and evaluated, which can mimic the full-size fiber topography. However, as the biomaterials and
fabrication technologies limit, no platform could be fabricated, which can be covered from the
nano-level to the micro-level fiber. Thus, two different platforms were used to cover the different
sizes of the topography separately. This technology limitation influenced the comparison of the
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cell differentiation between the micro-topography and nano-topography.
For the nano-, submicro-, and micro-fiber platform fabrication, stamping technology and
chemical etching technology were considered. These technologies can generate more specific
fiber and platform. However, as their high cost, they did not use in this dissertation. They will be
used as an alternative method in this dissertation or future studies to achieve other research
aims.
In summary, two fiber-based platforms (ACMFP and ASMFP) were designed and fabricated
with different size (60 μm, 90 μm, and 120 μm for the ACMFP; 0.7 μm, 1.5 μm, and 3 μm for the
ASMFP). All of them showed good alignment, stability, hydrophilicity, and biocompatibility with
specific treatment (Pluronic F127 for ACMFP and PDL/PLO for ASMFP). Thus, these platforms
support a suitable matrix used on topography-induced cell research and clinical application. The
data is collected using ASMFP produced by the same batch of the PCL solution. In the future,
additional experiments are required to complete the project, and we will use these platforms to
study the role of topography in stem cell differentiation.
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CHAPTER 3 – NEURAL DIFFERENTIATION OF THE ESC ON THE ACMFP AND ASMFP
(This chapter contains previously published material. See Appendix B.)
Abstract
The topography of the ECM plays a crucial role in cell attachment, growth, proliferation,
and differentiation. However, the different sizes of the topography in stem cell neural
differentiation are not precise yet. To study the role of the topography in stem cell fate, the
biomaterial platforms (ACMFPs and ASMFPs) were used to mimic the different sizes of the fiber
topography, as the last chapter reported and studied the role in stem cell fate determination.
The “step by step” method was used to induce the neural differentiation of the ESCs. The ESCs
induced NBs were seeded and cultured on different sizes of the ACMFPs and ASMFPs. The
immunofluorescence staining assay was used to identify the cell types on the platforms. The
result showed that both ACMFPs and ASMFPs could stimulate neuron-like cell generation. The
inhibition of the cell proliferation causes the stimulation of the ACMFPs induced neural
differentiation. The ASMFPs and part of the ACMFPs (60 and 90 μm) can guide the neurite
outgrowth. The different size of the fiber topography has a different level of the simulation in
neural differentiation and maturation of the ESCs, which indicates that the topography seems to
play a critical role in stem cell fate determination. The study and usage of biomaterial-induced
neural differentiation will contribute to ECM-induced cell growth, differentiation, and maturation
while it also contributes to future clinical application.
Introduction
Overview of the neural differentiation
As showed in Chapter 1, the ESC can be guided to differentiate into neural stem cells via
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multiple methods (Alizadeh et al., 2019; Liu et al., 2018b; Malczynska et al., 2019). The neural
stem cells, a tissue-specific stem cell, possess the ability to self-renew and have multipluripotency (Gonzalez et al., 2016; Grochowski et al., 2018). The definition of multi-pluripotency
of neural stem cell can only differentiate into the neural lineage cells, including neurons,
astrocytes, and oligodendrocytes(Gonzalez et al., 2016; Grochowski et al., 2018; Liu et al., 2018b).
The neuron is an electrically excitable cell that can transmit a signal from other sensory cells or
neurons. As it cannot proliferate, it cannot recover from damage, yet cell recovery is a primary
area of research (Menorca et al., 2013; Tran et al., 2018).
Astrocytes are a sub-type of glia cells, which help maintain neuronal metabolism (Nutma
et al., 2020). Oligodendrocytes are a type of large glial cell mainly located in the CNS. The primary
function of oligodendrocytes is to produce the myelin sheath to enhance the speed of neuronal
communication (Nutma et al., 2020; Stadelmann et al., 2019). In neural stem cell differentiation
research, multiple protein markers were used to label neural stem cells and three neural lineage
cells (Liu et al., 2018b). The generated yield of each type of lineage cell can be used to evaluate
the amount neural differentiation of each. In this dissertation, the cells were identified on the
ACMFP, ASMFP, and flat membrane groups to evaluate the role of the topography in stem cell
differentiation.
Physical factors induced neural differentiation
During stem cell development and differentiation in vivo and in vitro, the stem cell fate is
influenced by biophysical factors of the extracellular matrix (ECM) (Dong et al., 2017; Hu et al.,
2019; Jain et al., 2020; Lau and Hudson, 2010; Li et al., 2016; Zhu et al., 2019; Zimmermann and
Schaffer, 2019). The biophysical factors of ECM include micro/nano topography, matrix stiffness,
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and mechanical forces. In this chapter, we mainly focus on the topography induced the stem cell
research. There were currently two types of fiber platforms used for stem cell differentiation
studies. For example, the micro-fiber platform can change the cell growth direction and
morphology, while the nano-fiber platform can stimulate neural differentiation (Cheng and
Kisaalita, 2010; Yang et al., 2005). However, the role of the micro-fiber in neural differentiation
of the ESCs is not clear. Furthermore, the nano-fiber-based platform and micro-fiber function size
for neural differentiation and neurite outgrowth are also unclear. Therefore, this chapter mainly
focuses on the different sizes of the fiber-like topography in neural differentiation and neurite
outgrowth.
Rationale and hypothesis for Chapter 3
ESC-derived NBs were seeded and cultured on the ACMFPs and ASMFPs to study the role
of topography in neural differentiation. The neural stem cell and three neural lineage cells were
identified on all the platforms and their flat membrane. We hypothesized that both ACMFP and
ASMFP can stimulate neural stem cell differentiation and neural lineage cell differentiation while
also guiding the neurite outgrowth. This stimulation will enhance as their fiber size decreases. If
the ACMFP and ASFMP stimulate the differentiation, the mechanism would be explored.
Materials and methods
Neural differentiation of the ESC on the ACMFP and ASMFP
ESCs were differentiated into the NBs as a previously reported method(Liu et al., 2018b).
The ESC cell line (Manassas, VA, American Type Culture Collection) were cultured with the ESC
culture medium (Table 3) in the 37 °C and 5% CO2 incubator for 48 hours. The ESCs were
dissociated with TrypLE (Invitrogen) for 3 min in the 37 °C incubator and seeded into a 0.1%
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Gelatin (Invitrogen) coated 24-well cell culture dish (Corning). Different batches and passages of
ESCs (cells samples were from at least 6 batches independent experiments) were used in these
experiments and support the sufficient cell source for the following differentiation experiments.
The ESCs were cultured with the RA neural differentiation medium for 3-4 days in the 37 °C and
5% CO2 incubator named non-neural ectoderm (NNE). The NNE cells were dissociated with TrypLE
for 3 min in the 37 °C incubator and seeded into another 0.1% Gelatin coated 24-well cell culture
dish with RA neural differentiation medium for 3-4 days in the 37 °C and 5% CO2 incubator, which
was named as otic placode and otocyst (OPO). The OPO cells were dissociated with TrypLE for 3
min in the 37 °C incubator and seeded into the 24-well suspension culture dish (Corning). The
OPO cells were cultured with the suspension culture medium for 3-4 days in the 37 °C and 5%
CO2 incubator to form cell spheres named NB. ESC-derived NBs were dissociated, seeded, and
cultured on the different sizes of the ACMFPs, ASMFPs, and their flat membrane with 10%
coverslip medium in the 37 °C and 5% CO2 incubator. After six days, the ESNs were fixed with the
4% paraformaldehyde (PFA) for 10 minutes at room temperature.
Table 3. List of chemicals for the cell culture medium and solution
Name

ESC culture
medium
RA neural
differentiation
medium
293T culture
medium
Suspension
culture medium
10% coverslips
culture medium
Blocking solution
Working solution

Ingredient (Company)
45% DMEM High glucose (Logan, UT, Hyclone), 45% DMEM/F12 GlutaMAX (Carlsbad,
CA, Invitrogen), 10% Knockout FBS (Invitrogen), 1% MEM (Invitrogen), 1% NEAA
(Invitrogen), 55 µM 2-ME (Invitrogen), and 1,000 unit/mL LIF (Millipore).
45% DMEM High glucose (Hyclone), 45% DMEM/F12 GlutaMAX (Invitrogen), 10% FBS
(Gaithersburg, MD, Gibco), 1% MEM (Invitrogen), 1% NEAA (Invitrogen), 55 µM 2-ME
(Invitrogen), 100 µg/mL Ampicillin (Invitrogen), and 10-7 M all-trans RA (Sigma).
90% DMEM High glucose (Hyclone), 10% FBS (Gibco), and 100 µg/mL Ampicillin
(Invitrogen)
97% DMEM/F12 GlutaMAX, 1% N-2 supplement 100x, 2% B-27 Supplement 50x, 55
µM 2-ME (Invitrogen), 20 ng/mL EGF, and 20 ng/mL FGF-2 (All from Invitrogen).
45% DMEM/F12 GlutaMAX (Invitrogen), 45% Neurobasal (Invitrogen), 10% FBS
(Gibco), 55 µM 2-ME (Invitrogen), 100 µg/mL Ampicillin (Invitrogen), and 20 ng/mL
NGF (Invitrogen).
5% Donkey serum (West Grove, PA, Jackson IR) and 0.2% Triton X-100 (St. Louis, MO,
Sigma) of the DPBS (Sigma)
1% Donkey serum (Jackson IR) and 0.04% Triton X-100 (Sigma) of the PBS (Sigma)
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Evaluation of the NBs on the ACMFPs
To study the role of the ACMFP in neural stem cell differentiation, immunofluorescence
staining assays were used for cell identification on each platform (Figure 23). The fixed ESNs (at
least 3-6 independent ESNs differentiated from different batches of ESCs were used in the
following experiments) with platforms were treated with blocking solution (Table 3) at room
temperature for 1-2 hours. The ESNs were treated with the primary antibodies (Anti-NESTIN and
anti-SOX2, Table 4; each antibody was used for 3-6 independent cells staining experiments) of
the working solution (Table 3) in the 4 °C refrigerator overnight. ESNs were rinsed with PBS three
times and treated with the related secondary antibodies (Table 5) and nuclei marker (DAPI,
Invitrogen) at room temperature for 1-2 hours. The ESNs were rinsed with PBS three times to
remove the residual reagent (working solution with left of secondary antibodies). The ESNs were
observed and imaged by Leica SPE confocal microscopy. The number and percentage NESTIN,
SOX2, and NESTIN & SOX2 positive cells in each image were counted for the following
quantification studies.

Figure 23. Diagram for the neural stem cell identification on the ACMFP. ESC-derived NBs were
seeded and cultured on the 60 μm, 90 μm, 120 μm ACMFPs and PLGA flat membrane (control)
for six days. The fixed ESNs with platforms were stained with the neural stem cell marker (NESTIN
and SOX2) and cell nuclei marker (DAPI). The percentage of the NESTIN, SOX2, and NESTIN &
SOX2 double-labeled cells in all groups were used to evaluate the role of the ACMCPs in neural
stem cell differentiation.
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Table 4. Primary antibody list for immunofluorescence in Chapter 3
Primary antibody

Company

Species

Catalog number

Dilution

SOX2
NESTIN
GFAP
TUJ1
MOG
NF-L
KI-67

R&D
DSHB
STCZ
AVES
Millipore
AVES
Thermofisher

Goat
Mouse
Goat
Chicken
Mouse
Chicken
Mouse

AF2018
RAT-401
SC-6170
TUJ
AB5680
NFL
PA5-19462

1:200
1:100
1:200
1:500
1:200
1:1500
1:400

Table 5. Secondary antibody list for immunofluorescence in Chapter 3
Secondary antibody

Alexa Fluor 488 Donkey antiMouse IgG
Alexa Fluor 488 Donkey antiChicken IgY
Cy3 Donkey anti-Chicken IgY
Cy3 Donkey anti-Mouse IgG
Cy3 Donkey anti-Goat IgG
Alexa Fluor 647 Donkey antiChicken IgY
Alexa Fluor 647 Donkey antiMouse IgG
Alexa Fluor 647 Donkey antiGoat IgG

Company

Cat #

Combined
primary
antibody

Dilution

Jackson IR

715-546-150

MOG

1:500

Jackson IR

703-546-155

TUJ1

1:500

Jackson IR
Jackson IR
Jackson IR

703-166-155
715-166-150
705-166-147

TUJ1
NESTIN; KI67
GFAP

1:500
1:500
1:500

Jackson IR

703-496-155

NF-L

1:500

Jackson IR

715-496-150

MOG

1:500

Jackson IR

705-496-147

SOX2; GFAP

1:500

Evaluation of the ESNs on the ACMFPs and ASMFPs
To study the role of the ACMFP and ASMFP in neural differentiation, the
immunofluorescence staining assays were used for cell identification on the platforms (Figure
24). The fixed ESNs (at least 3-6 independent ESNs differentiated from different batches of ESCs
were used in the following experiments) were treated with blocking solution (Table 3) at room
temperature for 1-2 hours. The ESNs were treated with the primary antibodies (Anti-MOG, antiTU1J, and anti-GFAP, Table 4; each antibody was used for 3-6 independent cells staining
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experiments) of the working solution (Table 3) in the 4 °C refrigerator overnight. ESNs were rinsed
with PBS three times and treated with the related secondary antibodies (Table 5) and nuclei
marker (DAPI, Invitrogen) at room temperature for 1-2 hours. The ESNs were rinsed with PBS
three times to remove the residual reagent (working solution with left second antibodies). The
ESNs were observed and imaged by Leica SPE confocal microscopy. The number and percentage
of MOG, TUJ1, and GFAP positive cells in each image were counted for the following
quantification studies.

Figure 24. Diagram for the neural lineage cells identification on the ACMFP and ASMFP. ESCderived NBs were seeded and cultured on the 0.7 μm, 1.5 μm, and 3 μm ACMFPs, ASMFPs, and
their flat membrane (control) for six days. The fixed ESNs with platforms were stained with the
MOG (oligodendrocyte marker), TUJ1 (neuron marker), GFAP (astrocyte marker), and cell nuclei
marker (DAPI). The percentage of the MOG, TUJ1, and GFAP positive cells in all groups were used
to evaluate the role of the ACMCPs in neural differentiation.
Initial cell attachment assay
The initial attachment needed to be tested on the ACMFPs to clarify whether the ACMFPs
stimulated neural differentiation by influence the cell attachment. The same volume and
concentration of the dissociated NBs (NBs were from 3 independent batches cell differentiation)
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were seeded and cultured on the ACMFPs and PLGA flat membrane with 10% coverslip medium
in the 37 °C and 5% CO2 incubator for 4 hours (Figure 25). After the cell attached, the samples
were stained with DAPI (1:500) in the 37 °C and 5% CO2 incubator for 20 minutes. The samples
were imaged by Leica DMI 3000B epifluorescence microscopy. The number of the DAPI positive
cells were counted in the images to evaluate the cell initial attachment on the ACMFP.

Figure 25. Diagram for the initial cell attachment evaluation. The same volume and
concentration neural stem cells were seeded and cultured on the ACMFP and PLGA flat
membrane (control) for 4 hours. After that, the cells attached on the platforms were stained with
DAPI (cell nuclei marker). The number of the DAPI positive cells were counted in the images to
evaluate the cell initial attachment on the ACMFP.
Cell proliferation test
The cell proliferation needed to be tested on the ACMFPs to clarify whether the ACMFPs
stimulated neural differentiation by influencing cell proliferation. The same volume and
concentration of the dissociated NBs were seeded and cultured on the ACMFPs and PLGA flat
membrane with 10% coverslip medium in the 37 °C and 5% CO2 incubator (Figure 26). After 6
days, the fixed samples (3 independent cells differentiated from different batches of ESCs) were
treated with blocking solution (Table 3) at room temperature for 1-2 hours. The cells were
treated with the primary antibodies (Table 4; anti-KI67 was used for 3 independent cells staining
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experiments) of the working solution (Table 3) in the 4 °C overnight. Cells were rinsed with PBS
three times and treated with the related secondary antibodies (Table 5) and nuclei marker (DAPI,
Invitrogen) at room temperature for 1-2 hours. The cells were rinsed with PBS three times to
remove the residual reagent (working solution with left second antibody). The cells were
observed and imaged by Leica SPE confocal microscopy. The percentage of KI67 positive cells in
each image was counted for the following quantification study.

Figure 26. Diagram for the cell proliferation evaluation. The same volume and concentration
neural stem cells were seeded and cultured on the ACMFP and PLGA flat membrane (control) for
6 days. After that, the cells were stained with KI-67 (proliferating cell marker) and DAPI (cell nuclei
marker). The percentage of the KI67 positive cells were counted in the images to evaluate the
cell proliferation on the ACMFP.
Neurite outgrowth of the ESNs on the ACMFPs and ASMFPs
To study the role of the ACMFP in neurite outgrowth, immunofluorescence staining
assays were used for cell identification on the platforms. The fixed ESNs (at least 3-6 independent
ESNs differentiated from different batches of ESCs were used in the following experiments) with
platforms treated with blocking solution (Table 3) at room temperature for 1-2 hours. The ESNs
were treated with primary antibodies (Anti-NF-L or anti-TU1J, Table 4; each antibody was used
for 3-6 independent cells staining experiments) of the working solution (Table 3) in the 4 °C
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refrigerator overnight. ESNs were rinsed with PBS three times and treated with the related
secondary antibodies (Table 5) and nuclei marker (DAPI, Invitrogen) at room temperature for 12 hours. The ESNs were rinsed with PBS three times to remove the residual reagent (working
solution with second antibodies). The ESNs were observed and imaged by Leica SPE confocal
microscopy. The length and direction of the NF-L or TUJ1 positive cells’ neurite in each image
were measured for the following quantification studies.
Quantification study and statistical analysis
To identify and quantify the neural stem cell yield on the ACMFPs, the
immunofluorescence images of the NBs on the 60 μm, 90 μm, 120 μm ACMFPs and PLGA flat
membrane were collected and analyzed. The positive cells of NESTIN, SOX2, and DAPI (samples
(n) were from 3 independent experiments with same immunofluorescence staining) in the ESNs
on the 60 μm, 90 μm, 120 μm ACMFPs and PLGA flat membrane were counted by the cell counter
plugin module of Image J software (NIH). The percentage of the positive cells was equal to the
number of SOX2, NESTIN, and SOX2 & NESTIN double-labeled cells over the number of DAPI
positive cells (the total number of independent measurements between all treatment groups is
6, samples (n) were from 3 independent experiments).
To identify and quantify the new generated neural lineage cell types on the ACMFPs and
ASMFPs, the immunofluorescence images of the ESNs on the 60 μm, 90 μm, 120 μm ACMFPs (the
total number of independent measurements between all treatment groups is 12, samples (n)
were from 4 independent experiments), 0.7 μm, 1.5, μm, 3 μm ASMFPs (the total number of
independent measurements between all treatment groups is 24, samples (n) were from 3
independent experiments) and their flat membranes (control) were collected and analyzed. The
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positive cells of MOG, TUJ1, GFAP, and DAPI (samples (n) were from 3-4 independent
experiments with immunofluorescence staining) in the ESNs on the 60 μm, 90 μm, 120 μm
ACMFPs and their flat membrane were counted by the cell counter plugin module of Image J
software (NIH). The percentage of the positive cells was equal to the number of MOG, TUJ1, and
GFAP cells over the number of DAPI positive cells (the total number of independent
measurements between all treatment groups is 12, samples (n) were from 4 independent
experiments for ACMFPs; the total number of independent measurements between all
treatment groups is 24, samples (n) were from 3 independent experiments for ASMFPs).
To identify and quantify the initial cell attachment on the ACMFPs, the
immunofluorescence images of the NBs on the ACMFPs (the total number of independent
measurements between all treatment groups is 8, samples (n) were from 3 independent
experiments) and PLGA flat membranes (control) were collected and analyzed. The DAPI positive
cells (samples (n) were from 3 independent experiments with immunofluorescence staining) on
the ACMFPs and PLGA flat membrane were counted by the cell counter plugin module of ImageJ
software (NIH). The number of the DAPI positive cells were used to evaluate initial cell
attachment (the total number of independent measurements between all treatment groups is 8,
samples (n) were from 3 independent experiments).
To identify and quantify the cell proliferation on the ACMFPs, the immunofluorescence
images of the NBs on the ACMFPs (the total number of independent measurements between all
treatment groups is 8, samples (n) were from 3 independent experiments) and PLGA flat
membranes (control) were collected and analyzed. The positive cells of KI67 and DAPI (samples
(n) were from 3 independent experiments with immunofluorescence staining) on the ACMFPs
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and PLGA flat membrane were counted by the cell counter plugin module of ImageJ software
(NIH). The percentage of the KI67 positive cells was used to evaluate cell proliferation (the total
number of independent measurements between all treatment groups is 8, samples (n) were from
3 independent experiments).
To study whether ACMFPs and ASMFPs can guide the neurite outgrowth direction, the
immunofluorescence images of the ESNs on the 60 μm, 90 μm, 120 μm ACMFPs (the total number
of independent measurements between all treatment groups is 10, samples (n) were from 3
independent experiments), 0.7 μm, 1.5, μm, 3 μm ASMFPs (the total number of independent
measurements between all treatment groups is 24, samples (n) were from 3 independent
experiments) and their flat membrane were collected and analyzed. The alignment value of the
neurite on the 60 μm, 90 μm, 120 μm ACMFPs 0.7 μm, 1.5 μm, 3 μm ASMFPs and their flat
membrane was measured by the angle plugin module of the Image J software (NIH). The
alignment value of each fiber was equal to the angle between the neurite and the fiber direction.
The low alignment value and low standard derivation mean that the neurite was considered as a
high parallel stage. The high alignment value or high standard derivation means that the neurite
was considered as random growth stage.
As mentioned in the previous parts separately, all the samples were collected from 3-6
independent experiments. Each independent experiment indicated the repeated experiment
with independent platforms and cells. The number of n in each independent experiment means
the number of the independent platforms or culturing wells. For example, “the total number of
independent measurements between all treatment groups is 24 and samples (n) were from 3
independent experiments” indicated that the experiments were repeated 3 times with same
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protocol in different day. In each experiment, there were 8 separate samples in each group. A
total 24 (3 x 8) experiments were used for the quantification study and statistical evaluation.
The data are represented as mean ± standard deviation. Student’s t-test, a one-way
ANOVA with post-hoc Tukey HSD Test, and a two-way ANOVA test were used for statistical
significance. The actual statistical power was calculated by G*power. The p-values smaller than
0.05 were considered significant (P<0.05, marked with *; P<0.01, marked with ** in the figures).
Results
Neural stem cell differentiation on the ACMFPs
A previous report showed that the ESC would differentiate into the neural stem cells by
RA, EGF, FGF-2, and NGF treatments (Liu et al., 2018b). To study the role of the ACMSPs in the
neural stem cell generation, the cells on the 60 μm, 90 μm, 120 μm ACMFPs, and PLGA flat
membrane were double-labeled with two different types of neural stem cells marker (NESTIN
and SOX2) as previously reported (Hu et al., 2017; Liu et al., 2018b). The immunofluorescence
staining showed that 50.30 ± 6.84%, 44.18 ± 6.47%, 53.10 ± 7.29%, and 62.87 ± 5.60% cells on
the 60 μm, 90 μm, 120 μm, and PLGA flat membrane were labeled with the NESTIN. 47.63 ±
6.27%, 45.09 ± 9.04%, 43.76 ± 4.95%, and 56.87 ± 3.70% cells on the 60 μm, 90 μm, 120 μm, and
PLGA flat membrane were labeled with the SOX2. 42.07 ± 1.92%, 39.73 ± 3.38%, 38.75± 4.69%,
and 44.23 ± 6.79% cells on the 60 μm, 90 μm, 120 μm, and PLGA flat membrane were doublelabeled with the NESTIN & SOX2 (Figure 27). Quantification showed that the percentages of the
NESTIN & SOX2 positive cells in 60 μm, 90 μm, and 120 μm ACMFPs did not have significantly
difference with PLGA flat membrane (FR (5,15) = 2.489, P= 0.0784, FC (3,15)= 2.385, P= 0.1100 for
NESTIN & SOX2, actual statistical power = 1, two-way ANOVA; the total number of independent
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measurements between all treatment groups is 6, samples (n) were from 3 independent
experiments). The results indicate that the ACMFPs did not influence neural stem cell generation.

Figure 27. Neural stem cell differentiation on the ACMFP. (A) The ESCs derived NBs were
cultured on the flat membrane and three groups of the ACMFPs for six days. The
immunofluorescence staining 50.30 ± 6.84%, 44.18 ± 6.47%, 53.10 ± 7.29%, and 62.87 ± 5.60%
cells on the 60 μm, 90 μm, 120 μm, and PLGA flat membrane were labeled with the NESTIN.
47.63 ± 6.27%, 45.09 ± 9.04%, 43.76 ± 4.95%, and 56.87 ± 3.70% cells on the 60 μm, 90 μm, 120
μm, and PLGA flat membrane were labeled with the SOX2. 42.07 ± 1.92%, 39.73 ± 3.38%,
38.75± 4.69%, and 44.23 ± 6.79% cells on the 60 μm, 90 μm, 120 μm, and PLGA flat membrane
were double-labeled with the NESTIN & SOX2 (neural stem cell markers) (B) The quantification
study showed that the percentage of the Sox2/Nestin double-label cells on the flat membrane
and three ACMSPs groups which showed not significant difference among them (FR(5,15)= 2.489,
P= 0.0784, FC(3,15)= 2.385, P= 0.1100 for NESTIN & SOX2, actual statistical power = 1, two-way
ANOVA; the total number of independent measurements between all treatment groups is 6,
samples (n) were from 3 independent experiments). Figure published in Liu and colleagues, 2018
(Liu and Hu, 2018). Scale bar is 50 μm in A.
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Neural differentiation on the ACMFPs
A previous report showed that the ESCs would differentiate into neural lineage cells
(neuron and glia cells) by RA, EGF, FGF-2, and NGF treatments (Liu et al., 2018b). The neural
lineage cells included three different types, which are neuron, astrocyte, and oligodendrocyte
(Liang et al., 2020; Liu et al., 2018b; Tang et al., 2017). To study the role of the ACMSPs in the
neural lineage cell differentiation, the cells on the 60 μm, 90 μm, 120 μm ACMFPs and PLGA flat
membrane were labeled with different cell markers (MOG, marker for the oligodendrocyte; TUJ1,
marker for the neuron; GFAP, marker for the astrocyte) as previously reported (Li et al., 2016; Liu
et al., 2018b). Each antibody was used to label each type of neural lineage cell on the ACMFPs
and flat membrane. The results showed that 8.08 ± 2.13%, 8.82 ± 2.29%, 9.67 ± 2.38%, and 2.62
± 0.90 % cells on the 60 μm, 90 μm, 120 μm, and PLGA flat membrane were labeled with the TUJ1.
22.26 ± 4.56%, 21.69 ± 4.86%, 22.58 ± 5.31%, and 16.30 ± 2.85% cells on the 60 μm, 90 μm, 120
μm, and PLGA flat membrane were labeled with the GFAP (Figure 28). However, fewer MOG
positive cells were found in 60 μm, 90 μm, 120 μm ACMFPs, and PLGA flat membrane (data
showed the same result as the previous report (Liu et al., 2018b)). The quantification study
showed that the percentage of the TUJ1 or GFAP positive cells in 60 μm, 90 μm, 120 μm ACMFPs
were significantly higher than the PLGA flat membrane one (F(3,44)= 20.62, P<0.0001, and actual
statistical power= 0.99 for TUJ1, F(3,44)= 5.09, P=0.0041, and actual statistical power= 0.99 for
GFAP, one-way ANOVA with post-hoc Tukey HSD Test; the total number of independent
measurements between all treatment groups is 12, samples (n) were from 4 independent
experiments), while there was no significant difference among the 60
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Figure 28. Neural differentiation on the ACMFP. (A) The ESCs derived NBs were cultured on the
flat membrane and three groups of the ACMFPs for six days. The immunofluorescence staining
images show that 8.08 ± 2.13%, 8.82 ± 2.29%, 9.67 ± 2.38%, and 2.62 ± 0.90 % cells on the 60
μm, 90 μm, 120 μm, and PLGA flat membrane were labeled with the TUJ1 (neuron marker). 22.26
± 4.56%, 21.69 ± 4.86%, 22.58 ± 5.31%, and 16.30 ± 2.85% cells on the 60 μm, 90 μm, 120 μm,
and PLGA flat membrane were labeled with the GFAP (astrocyte marker). Fewer cells were
labeled with MOG (oligodendrocyte marker). (B) Quantification showed the percentage of the
MOG, TUJ1, and GFAP positive cells on the flat membrane and three ACMSPs groups. The
percentage of the TUJ1 or GFAP positive cells in 60 μm, 90 μm, 120 μm ACMFPs were significantly
higher than the PLGA flat membrane one (F(3,44)= 20.62, P<0.0001 for TUJ1, F(3,44)= 5.09, P=0.0041
for GFAP), while there was no significant difference among the 60 μm, 90 μm, and 120 μm
ACMFPs (FR(11,22)= 1.204, P=0.340, FC(2,22)= 1.536, P=0.2375 for TUJ1, FR(11,22)= 1.481, P= 0.208,
FC(2,22)= 0.1135, P=0.8932 for GFAP, two-way ANOVA; the total number of independent
measurements between all treatment groups is 12, samples (n) were from 4 independent
experiments, * means P<0.05, ** means P<0.01 ). (C) Quantification showed that the number of
the nuclei, TUJ1, and GFAP positive cells on the flat membrane and three ACMSPs groups. The
number of the TUJ1 positive cells did not have a significant difference among all groups (F(3,44)=
2.00, P=0.1264), while the number of the DAPI positive cells in the ACMFPs were significantly
higher than the PLGA flat membrane (F(3,44)= 55.38, P<0.0001, one-way ANOVA with post-hoc
Tukey HSD Test; the total number of independent measurements between all treatment groups
is 12, samples (n) were from 4 independent experiments, * means P<0.05, ** means P<0.01).
Figure published in Liu and colleagues, 2018 (Liu and Hu, 2018). Scale bar is 50 μm in A.
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μm, 90 μm, and 120 μm ACMFPs (FR (11,22) = 1.204, P=0.340, FC(2,22)= 1.536, P=0.2375 for TUJ1,
FR(11,22)= 1.481, P= 0.208, FC(2,22)= 0.1135, P=0.8932 for GFAP , and actual statistical power= 0.82
for GFAP, two-way ANOVA; the total number of independent measurements between all
treatment groups is 12, samples (n) were from 4 independent experiments). These results
indicate that ACMFPs seem to stimulate the neural lineage cell generation, especially for
generation of neurons. However, the quantification study also showed that the number of the
TUJ1 positive cells did not have a significant difference among all groups (F(3,44)= 2.00, P= 0.1264,
actual statistical power= 1, one-way ANOVA with post-hoc Tukey HSD Test; the total number of
independent measurements between all treatment groups is 12, samples (n) were from 4
independent experiments), while the number of the DAPI and GFAP positive cells in the ACMFPs
were significantly higher than the PLGA flat membrane (F(3,44)= 55.38 for DAPI, F(3,44)= 15.66 for
GFAP, P<0.0001 and actual statistical power=1, one-way ANOVA with post-hoc Tukey HSD Test;
the total number of independent measurements between all treatment groups is 12, samples (n)
were from 4 independent experiments). These results indicate that the increasing neural yield on
the ACMFPs was led by a reduction of total cells.
Mechanism of the ACMFPs induced neural differentiation
The neural yield increasing on the ACMFPs was led by the reduction of the total cell. Two
reasons may induce fewer cells on the ACMFP after 6 days of culture: the ACMFPs limiting cell
attachment or limiting cell proliferation. To prove these two hypotheses, the initial cell attaches
assay and cell proliferation assay was processed separately.
For the initial cell attachment evaluation, the dissociated NBs were seeded and cultured
on the ACMFP and PLGA flat membrane for 4 hours, followed by cell nuclei staining and
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quantification. The staining images showed 32.46 ± 7.83 and 38.87 ± 2.67 DAPI positive cells per
image attached to the ACMFP and PLGA flat membrane after 4 hours (Figure 29). However, the
quantification study showed that the number of the DAPI positive cells did not significantly differ
between the ACMFP group and PLGA flat membrane group (P=0.063, actual statistical power=
0.72, Student’s t-test; the total number of independent measurements between all treatment
groups is 8, samples (n) were from 3 independent experiments). This result indicated that the
ACMFPs did not influence the cell attachment.
Figure
29.
Cell
attachment
evaluation on the ACMFP. (A) The
ESCs derived NBs were cultured on
the flat membrane and ACMFPs for 4
hours. The immunofluorescence
images show that the 32.46 ± 7.83
and 38.87 ± 2.67 DAPI positive cells
per image were labeled in two groups
(B) The quantification study showed
that the number of the DAPI positive
cells did not have a significant
difference between the ACMFP group
and PLGA flat membrane group
(P=0.063, Student’s t-test; the total
number
of
independent
measurements
between
all
treatment groups is 8, samples (n)
were
from
3
independent
experiments). Figure published in Liu
and colleagues, 2018 (Liu and Hu,
2018). Scale bar is 100 μm in A.
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For the cell proliferation evaluation, the dissociated NBs were seeded and cultured on the
ACMFP and PLGA flat membrane for 6 days, followed by KI67 (proliferating cell marker) and DAPI
(cell nuclei marker) staining and quantification. The staining images showed that 53.00 ± 8.94%
and 68.52 ± 5.46% KI67 positive cells were on the ACMFP and PLGA flat membrane (Figure 30).
Quantification showed that the percentage of the KI67 positive cells on the ACMFPs was
significantly lower than the PLGA flat membrane one (P=0.0009, actual statistical power= 0.95,
Student’s t-test; the total number of independent measurements between all treatment groups
is 8, samples (n) were from 3 independent experiments). This result indicates that the ACMFPs
limit cell proliferation. These results suggest that the ACMFP might stimulate neural
differentiation by limiting cell proliferation.
Figure 30. Cell proliferation evaluation on
the ACMFP. (A) The ESCs derived NBs were
cultured on the flat membrane and ACMFPs
for 6 days. The immunofluorescence
images show that the 53.00 ± 8.94% and
68.52 ± 5.46% cells were labeled with Ki67
in two groups (B) The quantification study
showed that the percentage of the KI67
cells on the flat membrane and the ACMSP
groups, which shows the significant
decrease in the ACMFP group (P=0.0009,
Student’s t-test; the total number of
independent measurements between all
treatment groups is 8, samples (n) were
from 3 independent experiments; ** means
P<0.01). Figure published in Liu and
colleagues, 2018 (Liu and Hu, 2018). Scale
bar is 50 μm in A.
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Neurite outgrowth on the ACMFP
The growth direction of the neurites in the flat membrane and ACMFPs groups were used
to evaluate the role of the ACMFP in the neurite outgrowth. The ESNs on the 60 μm, 90 μm, 120
μm ACMFPs and PLGA flat membrane were labeled with NF-L (marker for the neuron and show
the direction of the neurite(Li et al., 2016; Liu et al., 2018b)). The result showed that lots of cells
were labeled by NF-L on the 60 μm, 90 μm, 120 μm ACMFPs and PLGA flat membrane (Figure 31).
Figure 31. Neurite outgrowth evaluation
on the ACMFP. (A) The ESCs derived NBs
were cultured on the flat membrane and
ACMFPs
for
6
days.
The
immunofluorescence images show that
the neurites of the ESNs were labeled with
NF-L in flat membrane and all ACMFP
groups (B) The quantification study
showed that the neurites alignment value
on the flat membrane and the ACMSP
groups, which shows the significant
decrease in the 60 and 90 μm ACMFP
group (F(3,36)= 38.50, P<0.0001, one-way
ANOVA with post-hoc Tukey HSD Test; the
total
number
of
independent
measurements between all treatment
groups is 10, samples (n) were from 3
independent experiments; ** means
P<0.01,). Figure published in Liu and
colleagues, 2018 (Liu and Hu, 2018). Scale
bar is 100 μm in A.

The quantification study showed that the alignment value of the ESNs on 60 μm and 90
μm ACMFPs were significantly lower than the 120 μm ACMFPs and PLGA flat membrane one
(F(3,36)= 38.50, P<0.0001, actual statistical power= 1, one-way ANOVA with post-hoc Tukey HSD
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Test; the total number of independent measurements between all treatment groups is 10,
samples (n) were from 3 independent experiments). The lower alignment value of the neurites
on the 60 μm and 90 μm ACMFPs indicated that the neurite on these ACMFPs were considered
as a high parallel stage. The results indicated that 60 μm and 90 μm ACMFPs seem to guide the
neurite-aligned growth.
Neural differentiation on the ASMFPs (Pilot Data)
The previous results showed that ACMFPs could stimulate neural differentiation (Liu and
Hu, 2018). However, the role of the ASMFPs in neural differentiation is not clear. To study the
role of the ASMFPs in the neural lineage cell differentiation, the cells on the 0.7 μm, 1.5, μm, 3
μm ASMFPs and flat membrane (PCL and glass) were labeled with different cell markers (MOG,
marker for the oligodendrocyte; TUJ1, marker for the neuron; GFAP, marker for the astrocyte) as
previously reported (Li et al., 2016; Liu et al., 2018b). Each antibody was used to label each type
of neural lineage cell on the ASMFPs and flat membrane. The result showed 50.91 ± 5.90%, 47.05
± 6.13 %, 40.37 ± 7.58%, 10.44 ± 3.12%, and 7.36 ± 2.48% cells were labeled by TUJ1 on the 0.7
μm, 1.5 μm, 3 μm ACMFPs and flat membrane (PCL and glass, Figure 32). 7.92 ± 2.35%, 8.05 ±
3.49%, 20.61 ± 7.04%, 17.35 ± 6.72%, and 17.18 ± 4.08% cells were labeled by GFAP on the 60
μm, 90 μm, 120 μm ACMFPs and flat membrane (PCL and glass, Figure 32). However, fewer MOG
positive cells were found in 0.7 μm, 1.5 μm, 3 μm ASMFPs, and flat membrane (data showed the
same result as the previous report (Liu et al., 2018b)).
The quantification study showed that the percentage of the TUJ1 positive cells in 0.7 μm,
1.5, μm, 3 μm ASMFPs were significantly higher than the glass and PCL flat membrane one
(F(4,115)= 353.84, P<0.0001, actual statistical power= 1, one-way ANOVA with post-hoc Tukey HSD
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Figure 32. Neural
differentiation on the
ASMFP (Pilot data). (A)
The ESCs derived NBs
were cultured on the
glass coverslip, flat
membrane, and three
groups of the ASMFPs
for six days. The
immunofluorescence
staining images show
that 50.91 ± 5.90%,
47.05 ± 6.13 %, 40.37 ±
7.58%, 10.44 ± 3.12%,
and 7.36 ± 2.48% cells
were labeled by TUJ1
on the 0.7 μm, 1.5 μm,
3 μm ACMFPs and flat
membrane (PCL and
glass). 7.92 ± 2.35%,
8.05 ± 3.49%, 20.61 ±
7.04%, 17.35 ± 6.72%,
and 17.18 ± 4.08% cells
were labeled by GFAP
on the 60 μm, 90 μm,
120 μm ACMFPs and
flat membrane (PCL
and glass). Fewer cells
were labeled with
MOG.
(B)
The
quantification
study
showed
that
the
percentage of the TUJ1 positive cells in 0.7 μm, 1.5, μm, 3 μm ASMFPs were significantly higher
than the glass and PCL flat membrane one (F(4,115)= 353.84, P<0.0001), while the percentage of
the 0.7 μm, 1.5, μm ASMFPs were significantly higher than 3 μm ASMFP one (F(2,69)= 15.77,
P=0.002, one-way ANOVA with post-hoc Tukey HSD Test; the total number of independent
measurements between all treatment groups is 24, samples (n) were from 3 independent
experiments). (C) The percentage of the GFAP positive cells in 0.7 μm and 1.5 μm ASMFPs were
significantly lower than the 3 μm ASMFPs, and glass or PCL flat membrane one (F(4,115)= 31.87,
P<0.0001), while there was no significant among the 3 μm ASMFPs, glass, and PCL flat membrane
one (F(2,69)= 2.41, P=0.0977, one-way ANOVA with post-hoc Tukey HSD Test; the total number of
independent measurements between all treatment groups is 24, samples (n) were from 3
independent experiments). The data is collected using ASMFP produced by the same batch of the
PCL solution. Scale bar is 50 μm.
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Test; the total number of independent measurements between all treatment groups is 24,
samples (n) were from 3 independent experiments), while the percentage of the 0.7 μm, 1.5, μm
ASMFPs were significantly higher than 3 μm ASMFP one (F(2,69)= 15.77, P=0.002, actual statistical
power= 0.99, one-way ANOVA with post-hoc Tukey HSD Test; the total number of independent
measurements between all treatment groups is 24, samples (n) were

from 3 independent

experiments). On the other hand, the percentage of the GFAP positive cells in 0.7 μm and
1.5 μm ASMFPs were significantly lower than the 3 μm ASMFPs, and glass or PCL flat membrane
one (F(4,115)= 31.87, P<0.0001, actual statistical power= 1, one-way ANOVA with post-hoc Tukey
HSD Test; the total number of independent measurements between all treatment groups is 24,
samples (n) were from 3 independent experiments), while there was no significant among the 3
μm ASMFPs, glass, and PCL flat membrane one (F(2,69)= 2.41, P= 0.0977, actual statistical power=
1, one-way ANOVA with post-hoc Tukey HSD Test; the total number of independent
measurements between all treatment groups is 24, samples (n) were from 3 independent
experiments). Thus, all the results indicated that the ASMFPs could stimulate neural
differentiation, while the small size of the ASMFPs showed the best performance. In addition, the
small size of the ASMFPs can limit glia differentiation.
Neurite outgrowth on the ASMFP (Pilot Data)
The previous report showed that nano-fibers also could guide neurite outgrowth. The
neurite direction evaluation was analyzed in the glass, flat membrane, and all three ASMFPs
groups to evaluate these. The immunofluorescence staining showed that the TUJ1 positive cells,
which grew on the glass, flat membrane, and 3 μm ASMFP, showed direction randomly, while the
TUJ1 positive cells, which grew on the 0.7 μm and 1.5 μm ASMFPs showed the parallel
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morphology. It indicated that the small size of the ASMFPs seems to guide neurite outgrowth,
while it showed that the ASMFPs played a vital role in neurite outgrowth. As previously reported,
the small size of the ACMFPs can guide the neurite outgrowth direction. However, the role of the
ASMFPs in neurite outgrowth is not clear. To study this point, the growth direction of the neurites
in the flat membrane and ASMFPs groups were used to evaluate the role of the ASMFP in the
neurite outgrowth. The ESNs on the 0.7 μm, 1.5 μm, 3 μm ACMFPs and flat membrane were
labeled with TUJ1 (marker for the neuron and show the direction of the neurite (Hackelberg et
al., 2017; Liu et al., 2018b)). The result showed that lots of cells were labeled by TUJ1 on the 0.7
μm, 1.5 μm, 3 μm ASMFPs and flat membrane (Figure 33). The quantification study showed that
Figure 33. Neurite
outgrowth evaluation
on the ASMFP (Pilot
data). (A) The ESCs
derived
NBs
were
cultured on the flat
membrane and ASMFPs
for 6 days. The
immunofluorescence
images show the TU1J
positive
neurons’
neurites'
growth
direction in glass flat,
PCL flat, 0.7 μm, 1.5 μm,
and 3 μm ASMFP
groups.
The
quantification study showed that the alignment value of the ESNs’ neurites on the 0.7 μm, 1.5
μm, 3 μm ASMFPs were significantly lower than the flat membrane one (F(4,115) = 313.31,
P<0.0001, one-way ANOVA with post-hoc Tukey HSD Test; the total number of independent
measurements between all treatment groups is 24, samples (n) were from 3 independent
experiments). The lower alignment value of the neurites on the 0.7 μm, 1.5 μm, and 3 μm ASMFPs
indicated that the neurite on these ASMFPs were considered as a high parallel stage. The
alignment value of the 0.7 μm, 1.5 μm, and 3 μm ASMFPs showed an increasing tendency
significantly (F (2,69) = 34.41, P<0.0001, one-way ANOVA with post-hoc Tukey HSD Test; n=24,
samples were from 3 independent experiments). The data is collected using ASMFP produced by
the same batch of the PCL solution. Scale bar is 100 μm in A.
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the alignment value of the ESNs neurites on the 0.7 μm, 1.5 μm, 3 μm ASMFPs was significantly
lower than the flat membrane one (F (4,115) = 313.31, P<0.0001, actual statistical power= 1, oneway ANOVA with post-hoc Tukey HSD Test; the total number of independent measurements
between all treatment groups is 24, samples (n) were from 3 independent experiments). The
lower alignment value of the neurites on the 0.7 μm, 1.5 μm, and 3 μm ASMFPs indicated that
the neurite on these ASMFPs were considered as a high parallel stage. The alignment value of
the 0.7 μm, 1.5 μm, and 3 μm ASMFPs showed an increasing tendency significantly (F(2,69)= 34.41,
P<0.0001, actual statistical power= 1, one-way ANOVA with post-hoc Tukey HSD Test; the total
number of independent measurements between all treatment groups is 24, samples (n) were
from 3 independent experiments). The data is collected using ASMFP produced by the same
batch of the PCL solution. Additional experiments are required to complete the project.
Discussion
The purpose of this study was to identify the role of topography in neural differentiation.
The previous papers showed that the nano-pattern platform stimulated neural differentiation
while the micro-pattern platform guided the neurite outgrowth (Cheng and Kisaalita, 2010; Yang
et al., 2005). However, the detailed role of the topography in neural differentiation is not clear.
To study this aim, the ESC was guided to differentiate to the neural stem cell and neural linage
cells as previous “step by step” method (Liu et al., 2018b).
To study the role of the micro-topography in neural differentiation, the ESC-derived NBs
were seeded and cultured on the different sizes of the ACMFPs and the PLGA flat membrane
(control for the topography). The multiply protein markers were labeled the cells on the
platforms for the neural stem cell and neural lineage cell identification (Liu et al., 2018b). The
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results showed that the ACMFP could not influence neural stem cell differentiation, while it could
stimulate neural differentiation and glial differentiation. The mechanism testing results showed
that the affection of this simulation was caused by the limitation of the cell proliferation on the
ACMFPs. Otherwise, the small size (60 μm and 90 μm) of the ACMFP could guide the neurite
outgrowth, while the large size (120 μm) of the ACMFP could not.
To study the role of the nano- and submicro-topography in the neural differentiation, the
ESC-derived NBs were seeded and cultured on the different sizes of the ASMFPs and the flat
membrane (control for the topography). The multiply protein markers were labeled the cells on
the platforms for neural lineage cell identification (Liu et al., 2018b). The results showed that the
ASMFP could stimulate neural differentiation, while the small size (0.7 μm and 1.5 μm) of the
ASFMP could inhibit the glia differentiation. Otherwise, the ASMFP could guide the neurite
outgrowth. Smaller ASMFP showed better guidance for the neurite outgrowth.
This dissertation hypothesizes the fiber pattern active the Integrin receptor to decide the
stem cell differentiation. Different types of Integrins were expressed on the ESN cell membrane
(data not shown). However, these integrins' role in the topography-induced stem cell
differentiation and neurite outgrowth was not clear.

Moreover, the specific intracellular

pathway for this affection was not clear yet. The specific experiments, which included receptor
knock-out, overexpression, and inhibitor treatment, will be processed in the system in future
research. These future studies may clarify the mechanism for the topography-induced
stimulation.
In this chapter, we hypothesis that ACMFP and ASMFP could stimulate neural stem cell
differentiation and neural lineage cell differentiation. However, the result showed that the

70
ACMFP could not influence the neural stem cell differentiation, while the part of the ASMFP could
inhibit the glial differentiation. As a limitation of the technologies, only four groups of protein
markers can be labeled in one group of samples (Liu et al., 2018b). The cell identification from
the one or two protein markers is weak. Otherwise, the cell function assay was not used for the
neural differentiation evaluation, limiting the study of the role of the topography in stem cell
differentiation.
In summary, the ESC-derived NBs were cultured on the ACMFP and ASMFP. Both ACMFP
and ASMFP could stimulate neural differentiation and guide the neurite outgrowth. It indicated
that the topography played a vital role in neural differentiation. The multiply cell identify
experiments, cell function evaluation and mechanism would be tested in the future. The study
and usage of biomaterial-induced neural differentiation will contribute to ECM-induced cell
growth, differentiation, and maturation, while it also contributes to future clinical application.
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CHAPTER 4 – SYNAPTOGENESIS OF THE ESN ON THE DIFFERENT SIZE OF THE ASMFP
Abstract
The micro-environment of the ECMs plays a crucial role in neuron maturation and
synaptogenesis. However, the role of topography in the synaptogenesis between stem cell
differentiated neurons is not precise. The ESCs induced NBs were seeded and cultured on the
submicro- and nano-fiber platforms (ASMFPs). After six days, the ESNs generated and formed a
connection with other ESNs. The different synaptic markers (SV2, PSD93, and Syn1) were used to
label and evaluate the newly generated synapses between the ESNs as in previous reports. The
staining and quantification showed that the ESNs on the 0.7 μm and 1.5 μm ASMFPs expressed
more synaptic markers than the 3 μm ASMFP or the flat membrane. The results indicate that the
submicro- and nano-fiber platforms could stimulate the formation of the synapse in vitro. These
studies about the topography-induced ESNs synaptogenesis contribute importantly to stem cellbased research and future clinical therapy.
Introduction
Synaptogenesis of the ESN in vitro
Overview of the synaptogenesis
During development, neurons connect and form a functional structure at the end of the
neurites or axon, called the synapse (Palay, 1956; Perea et al., 2009). The synapse can transmit
the electro-chemical signal via the release and binding of neurotransmitters (Perea et al., 2009).
Several studies have focused on the study of synaptogenesis, synapse maturation, and synaptic
plasticity (Blanco-Suarez et al., 2018; Li et al., 2016; Liu et al., 2018b; Schafer et al., 2012;
Varoqueaux et al., 2006). In this dissertation, we mainly focused on synaptogenesis. Typically,
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synaptogenesis between two neurons can be divided into three steps: (1) the axon or neurite of
the neuron targets into other neurons; (2) synapse-like structure form at the end of the neurites;
(3) the new synapse expresses several synaptic protein markers, release of neurotransmitter and
electrophysiology activity. The auditory neuron, for example (Carricondo and Romero-Gomez,
2019), will target its upstream sensory cells (hair cells) and downstream cells (CN neurons) at the
end of SGNs development. The mature synapse will then form among these three cells and
transfer the signal from the hair cells to CN neurons in vivo.
Synaptogenesis between the stem cell-derived neurons
As previously reported, the ESC could differentiate into the ESNs, which expressed the
neuron-specific gene, protein, iron channel, and electrophysiological activity (Liu et al., 2018b).
In addition, synaptogenesis is also an index to evaluate a newly generated neuron. To study the
ability of the synaptogenesis between the ESN and native neurons, the co-culture assay or triculture assay was used (Chen et al., 2018; Liu et al., 2018b). The ESN were cultured with native
neurons for several days, following with synaptogenesis evaluation. Several methods could be
used for synaptogenesis evaluation (Chen et al., 2018; Liu et al., 2018b). Firstly, the physical
connection and morphology of synapses between neurons were observed and evaluated.
Secondly, the multiply synapse protein markers were used to label the synapse between the
connections. Lastly, the signal transmission between the connected neurons was tested by patchclamp assays in vitro. Our previous report showed that ESNs could make the synapse-like
structure with the native neurons in the co-culture assay in vitro (Liu et al., 2018b). However, the
connected ESNs expressed fewer synapse protein markers and showed low electrophysiological
activity. Bio-chemical treatment method was used to stimulate synaptogenesis with good results
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(Liu et al., 2018b). However, this method was only suitable for the in vitro culturing system,
suggesting another type of method needs to be considered.
Physical factor-induced synaptogenesis
During development, synaptogenesis of native neurons happens in a complex microenvironment in vivo (Govey et al., 2013; Keung et al., 2010; Lapointe et al., 2013). The microenvironment includes topographical information, physiological cues, soluble factors, and cell-cell
interactions. A previous report showed that a soft matrix could stimulate synaptogenesis (Zhang
et al., 2014). However, fewer reports show that the topography can stimulate the synaptogenesis
between the stem cell-derived neurons. In this dissertation, the ASMFPs were used to mimic the
submicro- and nano-topography and evaluate their role in the ESNs’ synaptogenesis.
Rationale and hypothesis for Chapter 4
The ESC-derived NBs were seeded and cultured on the ASMFPs to study the role of the
topography in synaptogenesis. The neuronal connection and synapse-specific protein markers
were identified and evaluated on the different platforms and a flat membrane. We hypothesized
that ASMFP can stimulate synaptogenesis between the ESNs. The stimulation will increase as
their fiber size decreases.
Materials and methods
Evaluation of synaptogenesis on the ASMFPs
The previous report showed that the ESC-derived ESNs have fewer synapses between
neural connections, as fewer synaptic markers were expressed along the connection (Liu et al.,
2018b). There has been no report that showed that the topography could stimulate the ESNs
synaptogenesis. To study this role of the topography in neural synaptogenesis, the NBs were
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seeded and cultured for 6 days on all the ASMFP groups and flat membranes (glass and PCL)
(Figure 34). The fixed ESNs on the platforms were treated with blocking solution (Table 3) at room
temperature for 1-2 hours. The ESNs on the platforms were treated with the primary antibodies
(Anti-SV2, anti-SYN1, anti-PSD93, AND anti-TUJ1; Table 6; each antibody was used for 3
independent cells staining experiment) the working solution (Table 3) 4 °C refrigerator overnight.
ESNs were rinsed with PBS three times and treated with the related secondary antibodies (Table
7) and nuclei marker (DAPI, Invitrogen) at room temperature for 1-2 hours. The ESNs were rinsed
with PBS three times to remove the residual reagent (secondary antibodies and working solution).
The ESNs were observed and imaged by Leica SPE confocal microscopy. The number and area of
the SV2, PSD93, and SYN1 positive puncta in each image were counted for the following
quantification studies.
Figure 34. Diagram of the
synaptogenesis evaluation on the
ASMFP. The ESC-derived NBs were
seeded and cultured on the 0.7 μm,
1.5 μm, and 3 μm ACMFPs, ASMFPs,
and their flat membrane (control) for
six days. The fixed ESNs with platforms
were stained with the SYN1 (presynapse marker), PSD93 (postsynapse marker), SV2 (synaptic vesicle
marker), and TUJ1 (neuron marker).
The number and area of the SV2,
PSD93, and SYN1 positive puncta in
each image were counted for the
following quantification studies.
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Table 6. Primary antibody list for immunofluorescence in Chapter 4
Primary antibody

Company

Species

Catalog number

Dilution

SV2
SYN1
PSD93
TUJ1

DSHB
STCZ
SYSY
AVES

Mouse
Goat
Rabbit
Chicken

SV2-A
SC-8295-R
124102
TUJ

1:50
1:200
1:200
1:500

Table 7. Secondary antibody list for immunofluorescence in Chapter 4
Secondary antibody

AMCA Donkey anti-Rabbit
IgG
Alexa Fluor 488 Donkey
anti-Chicken IgY
Cy3 Donkey anti-Mouse IgG
Alexa Fluor 647 Donkey
anti-Goat IgG

Company

Cat #

Combined
primary antibody

Dilution

Jackson IR

711-156-152

PSD93

1:500

Jackson IR

703-546-155

TUJ1

1:500

Jackson IR

711-166-150

SV2

1:500

Jackson IR

705-496-147

SYN1

1:500

Quantification study and statistical analysis
To identify and quantify the newly generated synapses on the ASMFPs, the
immunofluorescence images of the ESNs on the 0.7 μm, 1.5 μm, 3 μm ACMFPs and flat
membranes (glass and PCL) (the total number of independent measurements between all
treatment groups is 24, samples (n) were from 3 independent experiments) were collected and
analyzed. Each connected TUJ1 positive cells were collected in each immunofluorescence image,
which was considered a connected neuron-like cell and could form a synapse. The number and
total area of the SV2 and PSD93 & SYN1 colocalized puncta along one TUJ1 positive connection
were analyzed by the analyze particles plugin module of Image J software (each puncta size was
chosen as 0.4-3 μm2; the total number of independent measurements between all treatment
groups is 24, samples (n) were from 3 independent experiments for ASMFPs) as previously
reported (Liu et al., 2018b).
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As mentioned in the previous parts separately, all the samples were collected from 3-6
independent experiments. Each independent experiment indicated the repeated experiment
with independent platforms and cells. The number of n in each independent experiment means
the number of the independent platforms or culturing wells. For example, “the total number of
independent measurements between all treatment groups is 24 and samples (n) were from 3
independent experiments” indicated that the experiments were repeated 3 times with same
protocol in different day. In each experiment, there were 8 separate samples in each group. A
total 24 (3 x 8) experiments were used for the quantification study and statistical evaluation.
The data are represented as mean ± standard deviation. Student’s t-test, a one-way
ANOVA with post-hoc Tukey HSD Test, and a two-way ANOVA test were used for statistical
significance. The actual statistical power was calculated by G*power. The p-values smaller than
0.05 were considered significant (P<0.05, marked with *; P<0.01, marked with ** in the figures).
Results
A previous report showed that the ESC-derived ESNs have less synapse, which showed an
immature condition for signal transmission [ref]. To stimulate synaptogenesis between the ESNs,
the ASMFPs were used as a platform for the ESNs, which studied the role of the ASMFPs in
synaptogenesis. The ESCs derived NBs were seeded and cultured on the different sizes of the
ASMFPs to study the role of the ASMFPs in the stem cell-derived neuron’s synaptogenesis. The
immunofluorescence images showed several TUJ1 positive cells connected in all ASMFPs groups
and flat membrane (glass and PCL) (Figure 35). In addition, the SV2 (synaptic vesicle marker),
SYN1 (pre-synaptic marker), PSD93 (post-synaptic marker) were also labeled along the TUJ1
positive connection in the 0.7 μm, 1.5 μm, 3 μm ASMFPs groups, and flat membranes groups
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(Figure 34).

Figure 35. Connected ESNs from synapse on the ASMFP (Pilot data). The ESCs derived NBs were
seeded and cultured on the different sizes of the ASMFPs to study the role of the ASMFPs in the
stem cell-derived neuron’s synaptogenesis. The immunofluorescence images showed several
TUJ1 positive cells connected in all ASMFPs groups and flat membrane (glass and PCL). The SV2
(synaptic vesicle marker), SYN1 (pre-synaptic marker), PSD93 (post-synaptic marker) were also
labeled along the TUJ1 positive connection in the 0.7 μm, 1.5 μm, 3 μm ASMFPs groups, and flat
membranes groups. The data is collected using ASMFP produced by the same batch of the PCL
solution. Scale bar is 20 μm.
The quantification study showed that the number and total area of the SV2 positive
puncta along the connection in 0.7 μm and 1.5 μm ASMFPs were significantly higher than the 3
μm ASMFP, glass and PCL flat membrane one (Figure 36; P<0.0001, F(4,115)= 50.22 and actual
statistical power= 0.95 for puncta number and total area, F(4,115)= 44.84 and actual statistical
power= 0.88 for puncta number, actual statistical power= 0.98 for puncta area, one-way ANOVA
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with post-hoc Tukey HSD Test; n=24, samples were from 3 independent experiments).

Figure 36. Evaluation of the synaptogenesis of the ASMFP (Pilot data). (A) High magnificent
images of Figure 24 showed that the SV2 (arrowhead), SYN1 & PSD93 colocalization (red arrow)
were also labeled along the TUJ1 positive connection in the 0.7 μm, 1.5 μm, 3 μm ASMFPs groups,
and flat membranes groups. (B) The quantification study showed that the number and total area
of the SV2 positive puncta along the connection in 0.7 μm and 1.5 μm ASMFPs were significantly
higher than the 3 μm ASMFP, glass and PCL flat membrane one (F(4,115)= 50.22, P<0.0001 for
puncta number, F(4,115)= 44.84, P<0.0001 for total area, one-way ANOVA with post-hoc Tukey
HSD Test; the total number of independent measurements between all treatment groups is 24,
samples (n) were from 3 independent experiments). The number and total area of the PSD93 &
SYN1 colocalization positive puncta along the connection in 0.7 μm and 1.5 μm ASMFPs were also
significantly higher than the 3 μm ASMFP, glass and PCL flat membrane one (F(4,115)= 41.88
P<0.0001 for puncta number, F(4,115)= 39.71, P<0.0001 for total area, one-way ANOVA with posthoc Tukey HSD Test; the total number of independent measurements between all treatment
groups is 24, samples (n) were from 3 independent experiments). The data is collected using
ASMFP produced by the same batch of the PCL solution. Scale bar is 10 μm in A.
In addition, the number and total area of the PSD93 & SYN1 colocalization positive puncta
along the connection in 0.7 μm and 1.5 μm ASMFPs were also significantly higher than the 3 μm
ASMFP, glass, and PCL flat membrane one (Figure 36; F(4,115)= 41.88 for puncta number, F(4,115)=
39.71 for puncta area, P<0.0001 for puncta number and total area, one-way ANOVA with posthoc Tukey HSD Test; the total number of independent measurements between all treatment
groups is 24, samples (n) were from 3 independent experiments). The result indicated that the
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parts of the ASMFPs could simulate the synaptogenesis of the ESNs. The data is collected using
ASMFP produced by the same batch of the PCL solution. Additional experiments are required to
complete the project.
Discussion
The purpose of this study was to identify the role of topography in synaptogenesis.
Previous papers showed that the ESC-derived ESNs contained immature synapses, which showed
fewer synaptic markers along with the neural connection (Liu et al., 2018b). A biochemical
method was used to simulate synaptogenesis (Liu et al., 2018b). However, the role of the
topography in synaptogenesis is not clear. To study this aim, the ESC-derived NBs were seeded
and cultured on the different sizes of the ASMFPs and their flat membrane (control for the
topography). The multiply synapse protein markers were labeled the cells on the platforms for
synapse identification and evaluation (Liu et al., 2018b). The results showed that the small size
of the (0.7 μm and 1.5 μm) ASMFPs could stimulate the synaptogenesis between the ESNs
connection, while the large size (3 μm) of the ASMFP could not.
In this chapter, we hypothesis that ASMFP could stimulate synaptogenesis between the
ESNs connection. However, the result showed that only part of the ASMFP could stimulate
synaptogenesis. The functional size was less than 1.5 μm ASFMPs. The average diameter of the
ESN’s neurite was also 1.5 μm (data do not show) (Liu et al., 2018b). It is not clear whether the
size of neurite and fibers decided this simulation level. In addition, as the limitation of the
technologies, the electrophysical activity of the new synapse were not evaluated on the
platforms, which is a limitation in our conclusion regarding the role of the ASMFP in the synapse
maturation.
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In this dissertation, the submicro-fiber platform, which incorporated the TSP1 protein,
were considered to stimulate the synaptogenesis between ESNs. However, the experiments
showed that the small size ASMFPs (0.7 μm and 1.5 μm) could stimulate the synaptogenesis
between ESNs. So, the TSP1 did not involve in the dissertation. The protein incorporated fiber
system will be processed on the stem cell differentiation experiments to achieve other specific
aims in future research.
In summary, the ESC-derived NBs were cultured on the ASMFP. Part of the ASMFP could
stimulate synaptogenesis between the ESNs, suggesting that topography played a vital role in
synaptogenesis. The electrophysiology evaluation would be processed on the ASMFP groups to
test the synapse maturation in the future. In addition, the mechanism and intracellular pathway
could be tested in the future experiments. The study and usage of biomaterial-induced neural
differentiation will contribute to ECM-induced cell growth, differentiation, and maturation, while
it also contributes to future clinical application.
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CHAPTER 5 – CONCLUSIONS
This dissertation was mainly focused on the topography-induced the stem cell fate
determination. Two similar types of fiber platforms, ACMFP and ASMFP, were designed,
fabricated, and evaluated to achieve these aims. These fiber platforms have several advantages
for use in stem cell research. Firstly, they have good biocompatibility showing little or no toxicity.
Secondly, they are high or good in alignment. The fibers in the platform showed a parallel pattern
that can use to build the parallel nerve tissue. Thirdly, their fiber size is controllable in different
scale ranges. To mimic the whole size range from the micro-meter to the nano-meter, the ACMFP
were designed into three size types: 60 μm, 90 μm, and 120 μm, while the ASMFP were also
designed into three size-types which are 0.7 μm 1.5 μm, and 3 μm. Lastly, the platform's fibers
show no gaps or no blank, which support an intact platform for cell attachment and growth.
Moreover, Pluronic F127 and PDL/PLO were used to treat and overcome the ACMFP’s shrinkage
and ASMFP’s hydrophobic. Overall, two good platforms were available for the topographyinduced stem cell differentiation study. All ASMFP experiments were performed using ASMFP
produced by the same batch of the PCL solution, so additional experiments are required to
complete the project.
The ESCs derived NBs were cultured on the ACMFP and ASMFP to evaluate the role of the
topography in neural differentiation, neurite outgrowth, and synaptogenesis (Table 8 &9). The
results suggested that the micro-pattern fiber did not influence the neural stem cell
differentiation. All the fiber platforms could stimulate neural differentiation. The micro-pattern
made this effect by inhibiting cell proliferation. Small submicro- & nano-fiber pattern could inhibit
the glia differentiation. In addition, the small micro-fiber pattern and submicro- & nano-fiber
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pattern could guide the neurite outgrowth direction. The effect of this stimulation was decrease
as the fiber size increase, which showed a linear tendency. Lastly, small size of the submicro- &
nano-fiber pattern could simulate the synaptogenesis between the ESNs. In conclusion, the fiberpattern topography seems to contribute the neural differentiation and maturation, which play a
crucial role in stem cell fate determination.
Table 8. Conclusion for the stem cell fate on the ACMFPs
Group

Neural stem
cell
differentiation

Neural
differentiation

Glia
differentiation

Cell
attachment

Cell
proliferation

Neurite
outgrowth
direction

----

----

----

----

----

----

----

↑↑

↑

N/A

N/A

↑↑

----

↑↑

↑

----

↓↓

↑↑

----

↑↑

↑

N/A

N/A

----

PLGA
flat
60
μm
90
μm
120
μm

(---- means no significant difference; ↑means significant increase; ↓means significant decrease; N/A means not
test).

Table 9. Conclusion for the stem cell fate on the ASMFPs (Pilot data)
Group

Neural
differentiation

Glia
differentiation

Neurite outgrowth
direction

Synaptogenesis

Glass flat
PCL flat
0.7 μm
1.5 μm
3 μm

------↑↑↑
↑↑↑
↑↑

------↓↓
↓↓
----

------↑↑↑
↑↑
↑

------↑↑
↑↑
----

(---- means no significant difference; ↑means significant increase; ↓means significant decrease).
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The physical cues, which included topography, stiffness, and mechanical forces, can
influence the stem cell renewal, differentiation, and maturation in vivo and in vitro. The nanotopography of the ECM can stimulate the neural differentiation of the stem cells, while the microtopography of the ECM can guide the neurite outgrowth. However, the role and functional size
of the micro- and nano-topography in the stem cell fate determination is not clear yet. To study
this aim, two biomaterial based aligned fiber platforms (ACMFP and ASMFP) were designed,
fabrication and evaluated to cover the micro-, submicro-, and nano-fiber topography, which used
to study the neural differentiation and maturation of the ESCs. All these platforms were showed
good alignment, contiguous, and biocompatibility via the physical factor assay, biocompatibility
assay evaluation. The results showed three different gradient sizes of the platforms were
fabricated in two type of platforms, which are 60 μm, 90 μm, 120 μm in ACMFPs and 0.7 μm, 1.5
μm, 3 μm in ASFMPs. The ESCs derived NBs were cultured on all platforms and their control flat
membranes for six days, which followed with immunofluorescence staining. The result showed
that all the ACMFPs and ASMFPs could stimulate the neural lineage cell differentiation. The
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affection of the ACMFPs induced the neural differentiation stimulate may cause by limit the cell
proliferation. Part of the ACMFPs and ASMFPs can guide the neurite outgrowth direction. Part of
the ASMFPs can stimulate the synaptogenesis. Overall, the micro-, submicro-, and nano-fiber
pattern platforms seem to play a key role in the stem cell determination with different
stimulation levels and types. The study of the topography induced stem cell differentiation may
contribute the stem cell research and open a new way for clinical therapy in the future.
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